Get In Touch

Email tnaved@amity.edu
Phone 0120-4392472, 9811645860

AMITY INSTITUTE OF PHARMACY (AIP)

Faculty

home // Faculty

Prof. (Dr.) Havagiray Chitme

BioSketch

Dr. Chitme completed his doctoral studies at Bundelkhand University, Jhansi in 2003. He currently works as a Professor of Pharmacology and Dy. Director of Amity Institute of Pharmacy. His areas of research interest include the clinical side of pharmacology, especially cancer, PCOS and metabolic syndrome. He completed research projects funded by Bayer Pharmaceuticals, Germany; The Research Council, Oman; Najran University, Saudi Arabia along with other institutes. He believes in building teams to find solutions to real-life problems through a multidisciplinary research approach. He published more than 100 research papers, patented 26 applications, presented papers at National and international level, delivered invited talks, chaired multiple scientific sessions, conducted National and international conferences, seminars, symposium and workshops. He believes that the research outcome must benefit society and classroom students.

 

RESEARCH INTERESTS

«  PCOS

«  Cancer

Metabolic syndrome

SELECTED PUBLICATIONS

  1. A MultiModal Approach to investigate Desmodium Gangetium’s influence on stress induced male infertility In vivo In Vitro and In Silico Assessment, Biomedicine and Pharmacotherapy, 2024, 173, 116358 (IF 7.5)
  2. Differential Gene Expression Analysis of Human Ovarian Follicular Cumulus and Mural Granulosa Cells Under the Influence of Insulin in IVF Ovulatory Women and Polycystic Ovary Syndrome Patients Through Network Analysis. Endocrine Research, 2023 (https://doi.org/10.1080/07435800.2023.2272629) (IF 4.0) (SCI)
  3. Protein Expression and Bioinformatics Study of Granulosa Cells of Polycystic Ovary Syndrome Expressed Under the Influence of DHEA. Clinical Medicine Insights: Diabetes and Endocrinology, 2023 (IF 4.3) (SCI) 10.1177/11795514231206732
  4. Regulation of insulin resistance, lipid profile and glucose metabolism associated with Polycystic ovary syndrome by Tionsopra cordifolia. Nutrients, 2023, 15, 2238. https://doi.org/10.3390/nu15102238 (IF 6.076) (SCI)
  5. Genome-wide association study for single nucleotide polymorphism associated with mural and cumulus granulosa cells of PCOS (polycystic ovary syndrome) and non-PCOS patients. Future Journal of Pharmaceutical Sciences, 9, 27, 2023.  (SCI) https://doi.org/10.1186/s43094-023-00475-3 (IF 2.6)

 

 

Dr. Tanveer Naved

Dy. Dean – Health & Allied Sciences and Professor & Centre Head – Pharmacognosy & Phytochemistry, Amity Institute of Pharmacy

•         University Gold Medal for securing first rank in M. Pharm. in Pharmacognosy & Phytochemistry.

•         Nominated as Corresponding Authority Member from India under Drug Research & Clinical Department by World Health Organization (WHO)

•         Member, Academic Council, Delhi Pharmaceutical Sciences and Research University (DPSRU), Delhi.

•         Member, Executive Council, Indian Pharmaceutical Association (IPA), Delhi Branch.

•         Reviewer & Expert -   National Medicinal Plants Board, Ministry of AYUSH, Govt. of India

RESEARCH INTERESTS

(Major scientific fields of interest), Pharmacognosy, Phytochemistry, Pharmacology & Natural Products

SELECTED PUBLICATIONS

  1. Hayat M. Mukhtar, S. H. Ansari, M. Ali and T. Naved, New oleanene and fernane type triterpenes from stem bark of Betula pendula Roth., 2003, Vol. 58, No. 9, pp. 671-673, Die PHARMAZIE,Govi-Verlag-Pharmazeutische Gesellschaft der DDR; Deutsche Arzneibuch-Kommission, CrossRef test user, Germany, ISSN: 0031-7144,
  2. T. Naved, J. I Siddiqui, S. H Ansari, Hayat M. Mukhtar and M. Ali, Recent Developments In Phytochemical and Pharmacological Studies on Juglans regia A Review, 2004, Vol. 2   No. 12, pp. 81-84, The Pharma Review,  Kongposh Publications Pvt.,  Ltd., New Delhi, 0973-399X,
  3. Phytoconstituents from the flowers of Calendula officinalis Linn. JMAPS, 25 (2003)
  4. Hayat M. Mukhtar, S. H. Ansari, T.   Naved and Z. A Bhat, Hypoglycemic activity of Psidium guajava Linn. Leaf extract, 2004, Vol. 4 No. 2 pp. , 186-189, Journal of Natural  Remedies, M/s Natural Remedies Ltd, Bangalore, ISSN:0972-5547
  5. S. H. Ansari Hayat M. Mukhtar, M. Ali, S. R, Mir, T. Naved and Z. A Bhat, Volatile Constituents of the Leaves of Psidium guajava Linn., 2005, Vol. 27, pp. 1-4, Journal of Medicinal and   Aromatic Plant Sciences (JMAPS), CDRI, Lucknow, ISSN 0253-7125,
  6. Hayat M. Mukhtar, S. H Ansari, M. Ali, T. Naved, Z. A Bhat, Effect of water extract of Psidium guajava leaves on alloxan-induced diabetic rats, 2004, Vol. 59, No.9, pp. 734-735, Die PHARMAZIE, Govi-Verlag-Pharmazeutische Gesellschaft der DDR; Deutsche Arzneibuch-Kommission, CrossRef test user, Germany         ISSN: 0031-7144
  7. Hayat M. Mukhtar, S. H. Ansari, M. Ali and T. Naved, New Compounds from Zizyphus vulgaris, 2004, Vol. 42, No. 7, pp. 508-511, Pharmaceutical Biology, Informa Pharmaceutical Science, USA, ISSN: 1388-0209 (prin, 1744-5116 (electronic)
  8. Recent Development in Phytochemical and Pharmacological Studies on Juglans regia A Review The Pharma Review, Vol 2, No. 12, Sep-Oct, 2004, 81-84.
  9. Hayat M. Mukhtar, S. H. Ansari, M. Ali, T. Naved and Z. A Bhat, Anti-hyperglycemic activity of Psidium guajava bark extract, 2004, Vol. 4, No. 2 pp. 150-154, Journal of Natural  Remedies, M/s Natural Remedies Ltd, Bangalore, ISSN:0972-5547
  10. Hayat M. Mukhtar, Ansari, S. H., Ali, M and Tanveer Naved, Anti-microbial Activity of Zizyphus vulgaris roots, 2004, Vol. 47, No. 22, pp. 27-29, Hamdard Medicus, Hamdard Foundation Pakistan, ISSN:0250-7188,OCLC: 7662983
  11. Herbal Immunomodulators – review article “The Pharma Review, Vol. 3 (13),  2004, 86-100.
  12. Hayat M. Mukhtar, S.H. Ansari, M. Ali, T. Naved, Z.A. Bhat, New ursane type of triterpenes from Zizyphus vulgaris roots, 2005, Vol. 43, No. 5, pp. 392-395, Pharmaceutical Biology, Informa Pharmaceutical Science, USA, ISSN: 1388-0209 (prin, 1744-5116),
  13. Hayat M. Mukhtar, S.H. Ansari, M. Ali, Tanveer Naved, A new D-lactone containing triterpene from the flowers of Calendula officinalis   Linn., 2004, Vol. 42, No. 4-5, pp. 305-307, Pharmaceutical Biology, Informa Pharmaceutical Science, USA, ISSN: 1388-0209 (prin, 1744-5116 ,
  14. Hayat M. Mukhtar, S. H. Ansari, M. Ali and T. Naved, Antifungal activity of Zizyphus vulgaris roots, 2003, Vol. 19, No. 4, pp. 26-28, Indian Journal of Natural Products, Society of Pharmacognosy, 0973-399X
  15. Hayat M. Mukhtar, S. H. Ansari, M. Ali, T. Naved and Z.A Bhat, Antifungal activity of Betula  pendula bark extract, 2004, Vol. 20, No.2, pp. 34-35, Indian Journal of Natural Products, Society of Pharmacognosy, ISSN/0970-129X
  16. T. Naved, S. H. Ansari, Hayat M. , Mukhtar, and M. Ali, New , triterpenic ester of oleanene-series,  from the flowers of Calendula,  officinalis Linn., 2005, Vol. 44,  (B),  pp. 1088-1091, Indian Journal of Chemistry, , CSIR, New Delhi, ISSN: 0376-4699
  17. Mukhtar HM1, Ansari SH, Ali M, Bhat ZA, Naved T., Effect of Cyamopsis tetragonoloba Linn. beans aqueous extract on blood glucose levels in normal and alloxan-induced diabetic rats. Indian Journal of Experimental Biology (December 2004), Vol. 42, 1212-1215.
  18. Hayat M. Mukhtar, S. H. Ansari, M.   Ali, Z. A Bhat and T. Naved, Effect of aqueous extract of Cyamopsis tetragonoloba Linn. beans on blood glucose levels in normal and alloxan-induced Diabetic rats, 2004,Vol. 42, PP. 1212-1215, Indian Journal of Experimental Biology, CSIR, New Delhi, ISSN:0019-5189
  19. T. Naved, J. I Siddiqui, S. H Ansari, Hayat M. Mukhtar, Immunomodulatory activity of Mangifera indiacca L. fruits, (cv. Neelam), 2005, Vol. 5, No.2, June, pp. 137-140, Journal of Natura  Remedies, M/s Natural Remedies Ltd, Bangalore, ISSN:0972-5547,
  20. Z. A Bhat, S. H Ansari, Hayat M. Mukhtar, T. Naved, J. I Siddiqui, N. A Khan, Effect of Aralia cachemirica Decne. root extracts on blood glucose level in normal and glucose loaded rats, 2005, Vol. 60, No.9, pp. 712-713, Die PHARMAZIE, Govi-Verlag-Pharmazeutische Gesellschaft der DDR; Deutsche Arzneibuch-Kommission, CrossRef test user, Germany, ISSN: 0031-7144,
  21. Hayat M. Mukhtar, S. H. Ansari, Z. A. Bhat and T. Naved, Antihyperglyceamic Activity of Cyamopsis tetragonoloba Beans on Blood Glucose Levels in Alloxan-Induced Diabetic Rats, 2006, Vol. 44, No.1, pp. 10-13, Pharmaceutical Biology, Informa Pharmaceutical Science, USA, ISSN: 1388-0209 (prin, 1744-5116, A review on chemistry and biological activity of Aegle marmelos Journal of Pharmaceutical Research Vol.5, No.2, April 2006, 46-50.
  22. Z. A Bhat, S. H. Ansari, Hayat M. Mukhtar, T. Naved, N. A Khan and R. A. Chashoo, Anti-yperglycaemic activity of the alcoholic extract of Aralia cachemirica Decne roots, 2005, Vol. 5, No. 2, June, pp. 160-164, Journal of Natura  Remedies, M/s Natural Remedies Ltd, Bangalore, ISSN:0972-5547
  23. Antidiabetic activity of an ethanol extract obtained from the stem bark of Psidium guajava (Myrtaceae) Pharmazie 61 (2006) 8
  24. Hayat M. Mukhtar, S. H. Ansari, Z. A. Bhat, T. Naved, P. Singh, Antidiabetic activity of ethanol extract obtained from stem bark of Psidium guajava (Myrtaceae), 2006 , Vol. 61, No. 8, pp. 725-727, Die PHARMAZIE, Govi-Verlag-Pharmazeutische Gesellschaft der DDR; Deutsche Arzneibuch-Kommission, CrossRef test user, Germany , ISSN: 0031-7144,
  25. Hayat M. Mukhtar, S. H. Ansari and T. Naved, Antifungal activity of Calendula officinalis flowers, 2007, Vol. 50, No.3, pp. 29-30, Hamdard Medicus, Hamdard Foundation Pakistan, ISSN:0250-7188,OCL: 7662983,
  26. Kriti Soni & Tanveer Naved, Swine Flu- Ongoing clinical trials and recent advances in vaccines, The Clinical Research Plus, June - 2010
  27. Mahek Arora, T. Naved, Pharmacognostical Standardisation and Physico-chemical evaluations of leaves of Verbascum thapsus Linn., International Journal of drug development & research, 3(1), 2011, 334-340.
  28. P. Kumar, S. Jha and T. Naved “Pharmacognostical Characterization of an Ayurvedic Powdered Formulation: Panchsakar Churna” InternationalJ of Res. in Pharm. and Chem., 1 (4), 2011, pp 1034-1041.
  29. Raina Mehra, Tanveer Naved*, Mahek Arora, Swati Madan, Standardization and Evaluation of Formulation Parameters of Tinospora Cordifolia Tablet, Journal of Advanced Pharmacy Education & Research,  Oct-Dec 2013 Vol 3 Issue 4
  30. Puspendra Kumar,corresponding author1 Shivesh Jha, and Tanveer Naved, Validated Modified Lycopodium Spore Method Development for Standardisation of Ingredients of an Ayurvedic Powdered Formulation Shatavaryadi Churna, African Journal of Traditional, Complementary and Alternative Medicines 2013; 10(6): 426–430.
  31. Puspendra Kumar, Shivesh Jha, Tanveer Naved. Validated Modified Lycopodium Spore Method Development for Standardization of Ingredients of an Ayurvedic Powdered Formulation-Shatavaryadi Churna. African Journal of Traditional Complementary Alternative Medicine. (2013) 10(6):426-430
  32. Puspendra Kumar, Shivesh Jha, Tanveer Naved. Pharmacognostical, Physicochemical and Elemental Investigation of An Ayurvedic Powdered Formulation: ShatavaryadiChurna. International Journal of Pharmaceutical Sciences and Research. (2013)4(10): 4058-4066.
  33. Puspendra Kumar, Shivesh Jha, Tanveer Naved. HPTLC Fingerprint Profile of Ingredients and Formulations of Shatavaryadi Churna: An Ayurvedic Formulation, International Journal of Phytomedicine. (2013) 5(4):467-474.
  34. Amrit Kumar Singh, Tanveer Naved, Dharam paul Attrey, Comparative Studies on Antioxidant Activity, Total Phenol Content and High Performance Thin Layer Chromatography Analysis of Seabuckthorn (Hippophae rhamnoids) leaves, Pharmacognosy Journal, 9 (2014).
  35. Amrit Kumar Singh, Dharam Paul Attrey, Tanveer Naved, Acute & sub-acute toxicity studies of pharmacologically active seabuckthorn leaf extract, International journal of Pharmacy and Pharmaceutical sciences, 06/14, 6 (06).
  36. Amrit Kumar Singh, Dharam Paul Attrey, Tanveer Naved, Effect of seabuckthorn extract on scopolamine induced cognitive impairment, Indian journal of experimental Biology, 10, 2012, 690-95.
  37. Amrit Kumar Singh, Dharam Paul Attrey, Tanveer Naved, Jyoti Katyal, Pharmacognostical Characterization & Preliminary Phytochemical Investigation of Seabuckthorn (Hippophae rhamnoides L.) Leaves, Indo global journal of Pharmaceutical sciences, 01-2012, 108-113
  38. Anjana Roy, Neerupma Dhiman*, Swati Madan, and Tanveer Naved, Pharmacognostical and Preliminary Pharmacological Investigation of whole plant extract of Cuscuta reflexa growing on different hosts plants, International journal of Phytopharmacology, 4(3), 2013, 190-194.
  39. Kriti Soni, Mahek Arora, Tanveer Naved, Comparative Antimicrobial Activity of Lawsonia Inermis, Mimosa Pudica, Cestrum Diurnum and Solanum Xanthocarpum, European journal of Pharmaceutical and Medical Research, 2(1), 2015, 450-457.
  40. Neha Dawar, Tanveer Naved, VK Tyagi, Stability studies of formulations containing Eucalyptus oil, Indo global journal of Pharmaceutical sciences, 3 (3), 2013, 174-180.
  41. Pradeep Tripathy, Tanveer Naved, Development of quality control parameters of Nymphaea stellate Willd, Internationale Pharmaceutical Sciencia, 3(4), 2013, 93-96.
  42. Supriya Bharti, Tanveer Naved, Anti-oxidant activity of some medicinal butters, International journal of drug development & research, 5(4), 2013, 336-339.
  43. Amrit Kumar Singh, Dharam P 1 2 aul Attrey and 3Tanveer Naved, Heavy Metal Analysis of Seabuckthorn Leaf Extract, Global Journal of Pharmacology 7 (4): 412-415, 2013, IDOSI Publications, 2013
  44. 1Singh Amrit Kumar, 1Attrey Dharam Paul* and 2Naved Tanveer, Bioactivity guided extraction of Seabuckthorn (Hippophae rhamnoides, L. ssp. turkestanica) leaves, Journal of Scientific & Industrial Research, Vol. 72, May 2013, pp. 307-311
  45. Arshia Berry1, Thomas Charles Guest1 and Tanveer Naved2*, Phytosomes: from Herbal Drug Delivery to Targeted Clinical Therapy, World Journal of Pharmaceutical Research, Volume 5, Issue 11, Review Article ISSN 2277– 7105
  46. Puspendra Kumar, Shivesh Jha, Tanveer Naved, Determination of essential and potentially toxic elements by Inductively Coupled Plasma-Optical Emission Spectrometry and In vitro Antioxidant evaluation of Shatavaryadi Churna: An Ayurvedic Formulation, International Journal of Drug Development and Research, 2015, 7(1), 23-30.
  47. P P Johna*b, Shivesh Jhab, Tanveer Navedc, Pharmacognostical Characterization of an Anti-Diabetic Polyherbal Formulation, Int. J. Drug Dev. & Res., January - March 2015 | Vol. 7 | Issue 1 | ISSN 0975-9344 |
  48. P. P. John *1, Shivesh Jha 2 and Tanveer Naved 3, Effect of Ingredients of a Local Antidiabetic Formulation in Enhancing the Antidiabetic Activity of Salacia Reticulata in Alloxan Induced Diabetic Rats, International Journal of Pharmaceutical Sciences and Research, John et al., IJPSR, 2016; Vol. 7(9): 3712-3720, E-ISSN: 0975-8232; P-ISSN: 2320-5148.
  49. Zahoor I, Singh S, Behl T, Sharma N, Naved T, Subramaniyan V, Fuloria S, Fuloria NK, Bhatia S, Al-Harrasi A, Aleya L. Emergence of microneedles as a potential therapeutics in diabetes mellitus. Environmental Science and Pollution Research. 2021 Nov 10:1-21.
  50. Singh A, Behl T, Sehgal A, Singh S, Sharma N, Naved T, Bhatia S, Al-Harrasi A, Chakrabarti P, Aleya L, Vargas-De-La-Cruz C. Mechanistic insights into the role of B cells in rheumatoid arthritis. International Immunopharmacology. 2021 Oct 1;99:108078.
  51. Sharma N, Zahoor I, Sachdeva M, Subramaniyan V, Fuloria S, Fuloria NK, Naved T, Bhatia S, Al-Harrasi A, Aleya L, Bungau S, Behl T, Singh S. Deciphering the role of nanoparticles for management of bacterial meningitis: an update on recent studies. Environmental Science and Pollution Research. 2021 Nov;28(43):60459-76.
  52. Singh S, Behl T, Sharma N, Zahoor I, Chigurupati S, Yadav S, Rachamalla M, Sehgal A, Naved T, Arora S, Bhatia S. Targeting therapeutic approaches and highlighting the potential role of nanotechnology in atopic dermatitis. Environmental Science and Pollution Research. 2022 Feb 23:1-26.
  53. Parul Grover, Lovekesh Mehta, Tanveer Naved Sandeep Kumar, Gorav Monga, Identification and Characterization of in vitro Metabolites of Belinostat by Rat Liver Microsomes using Ultra Performance Liquid Chromatography Coupled with Tandem Mass Spectrometry, Indian Journal of Pharmaceutical Education and Research, 56, S58-S66, 2022, 0.638
  54. Lovekesh Mehta, Tanveer Naved, Parul Grover, Monika Bhardwaj, Debaraj Mukherjee, Dushyanth R. Vennapu, Identification and characterization of new degradation products of belinostat using UHPLC-Q-TOF_MS/MS and in silico toxicity prediction, Journal of Liquid Chromatography and Related Technologies, 44 (5-6), 291-303, 2021, 0.987
  55. Lovekesh Mehta, Tanveer Naved, Parul Grover, Monika Bhardwaj, Debaraj Mukherjee, Development and validation of novel and highly sensitive stability-indicating reverse phase ultra-performance liquid chromatography method for quantification of ibrutinib and its ten degradation products    Indian Journal of Pharmaceutical Sciences, 82, 958-966, 2020, 0.97
  56. Lovekesh Mehta, Tanveer Naved, Parul Grover, Monika Bhardwaj, Debaraj Mukherjee, LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway, Journal of Pharmaceutical and Biomedical Analysis, 194, 113768, 2020, 3.93

 

Prof. (Dr.) Viney Lather

Google Scholar: https://scholar.google.co.in/citations?user=Dv3g8SsAAAAJ&hl=en

Scopus ID: https://www.scopus.com/authid/detail.uri?authorId=6507973142

Orcid ID: https://orcid.org/0000-0002-7323-3142

 

Educational Qualifications: B. Pharmacy (1999, M. D. University, Rohtak), M. Pharmacy (2002, MAHE, Manipal), PhD  (2006, M. D. University, Rohtak), MBA (2013, M. D. University, Rohtak)

Experience: Total of 22 years of National/International research (Industrial and Academic) experience in   Pharmaceutical Sciences (Drug Discovery and Development). Guided 11 PhD and 50 M. Pharm scholars, Supervising 02 PhD and 02 M.Pharm scholars

  1. Research Areas: Medicinal chemistry, Molecular Modeling, Chemo & Bioinformatics, Nanoparticulate Drug Delivery (Expertise in drug delivery systems like dendrimers, mesoporous silica nanoparticles, solid lipid nanoparticles, self-nanoemulsifying systems), Analytical Method Development
  2. Research Expertise: Development of nanoplatforms for drug delivery, Extensive experience with in silico tools for SBDD like docking, pharmacophore modeling, QSAR, Molecular dynamics, Homology modeling, Drug Discovery and development on therapeutic targets like Cancer: CDKs, CHKs, GSKs, MMPs; Inflammation: PDEs, COX; Diabetes & Metabolic disorders: GK, GSK-3, PPARs; Alzheimer’s: BACE; Antimicrobial resistance: β-lactamases, bacterial membrane protein inhibitors

c.       Publications, Awards, Achievements:

  • More than 120 National and International publications (Google Scholar h-index: 30, Citations: 3939, i-10 index: 66; Scopus h-index: 27, Cumulative I.F. > 300); 9 book chapters in books published by International publishers.
  • Research Grants: a. PI, Research Promotion Scheme, 2013-16, AICTE, INR 1900000/-

b. Co-PI, Research Promotion Scheme, 2012-14, AICTE, INR 1500000/-

c. Co-PI, Early Career Research Grant, 2012-14, SERB, INR 1580000/-

d. Received FDP and seminar grants from AICTE worth INR 1150000/-

  • Postdoc fellowship, Fundacao para a Ciencia e a Technologia, 2007-10, Portugal
  • Best Scientist Award, Jubilant Biosys Ltd. 2006.
  • Selected for Young Scientist Scheme, 2006 by Dept. of Science & Technology, Delhi.
  • Gold Medalist, M.Pharm, 2002
  • Rank Holder, B. Pharm, 1999
  • GATE 2000, 88.18 percentile
  • Received travel grants from DST (2004), SERB (2014), AICTE (2004).
  • Delivered more than 15 invited talks in National/International Conferences
  • Invited as session chair/resource person in more than 10 Conferences/Seminars
  • Reviewer for various international journals including Journal of Molecular Structure, Chemical Biology Drug Design, Bioorganic and Medicinal Chemistry

 

RESEARCH INTERESTS

Current Areas of Research: Nanodrug delivery for therapeutic areas like cancer, autoimmune disorders, AMR; Drug discovery and development for autoimmune disorders and Cancer; assessment of pharmaceutical residues in environmental resources.

 

SELECTED PUBLICATIONS

Recent publications:

·       Sharma H.K., Karna A., Verma S.K., Gupta P., Nagpal D., Kumar A., Pandita D., Mukherjee M., Parmar V.S., Aggarwal P., Lather V. Exploring the Synergistic Effect of Thymol with Oxacillin against Methicillin Resistant Staphylococcus aureus. Indian Journal of Microbiology.  2024. https://doi.org/10.1007/s12088-024-01311-9. Impact Factor-2.8.

·       Sharma H.K., Gupta P., Nagpal D., Mukherjee M., Parmar V.S., Aggarwal P., Lather V. Virtual screening and antimicrobial evaluation for identification of natural compounds as the prospective inhibitors of antibacterial drug resistance targets in Staphylococcus aureus. Fitoterapia. 168, 105554, 2023. Impact Factor-2.5, CiteScore-5.8

·       Das A., Prajapati A., Karna A., Sharma H. K., Uppal S., Lather V., Pandita D., Agarwal P. Structure-based virtual screening of chemical libraries as potential MELK inhibitors and their therapeutic evaluation against breast cancer. Chemico-Biological Interactions. 376, 110443, 2023. Impact Factor-5.168, CiteScore-9.

·       Grover R., Drall S., Poonia N., Jain G. K., Aggarwal G., Lather V., Kesharwani P., Pandita D., Goyal R. K. CD44 and CD133 aptamer directed nanocarriers for cancer stem cells targeting. European Polymer Journal. 183, 111770, 2023. Impact Factor-5.546, CiteScore-8.2

·       Hekmat A., Saso L., Lather V., Pandita D., Kostova I., Saboury A. A. Recent Advances in Nanomaterials of Group XIV Elements of Periodic Table in Breast Cancer Treatment. Pharmaceutics. 14(12), 2640, 2022. Impact Factor-6.525.

·       Musyuni P., Bai J., Sheikh A., Vasanthan S. K., Jain G. K., Abourehab M. A. S., Lather V., Aggarwal G., Kesharwani P., Pandita D. Precision medicine: Ray of hope in overcoming cancer multidrug resistance. Drug Resistance Updates. 65, 100889, 2022. Impact Factor-22.841, CiteScore-30.8.

·       Agarwal K., Srinivasan V., Lather V., Pandita D., Vasanthan K. S. Insights of 3D bioprinting and focusing the paradigm shift towards 4D printing for biomedical applications. Journal of Materials Research. 38, 112-141, 2023. Impact Factor-2.909.

·       Saini N., Grewal A. S., Lather V., Gahlawat S. K. Natural alkaloids targeting EGFR in non-small cell lung cancer: Molecular docking and ADMET predictions. Chemico-Biological Interactions. 358, 109901, 2022. Impact Factor-5.168, CiteScore-9.

·       Saini N., Lather V., Gahlawat S. K. Exploring phytochemicals from Himalayan medicinal plants as novel therapeutic agents. Anti-Cancer Agents in Medicinal Chemistry. 22 (9), 1674-1698, 2022. Impact Factor- 2.527, Citescore-4.0.

·       Singh S, Grewal A. S., Grover R., Sharma N., Chopra B., Dhingra A. K., Arora S., Redhu S., Lather V. Recent updates on development of protein-tyrosine phosphatase 1B inhibitors for treatment of diabetes, obesity and related disorders. Bioorganic Chemistry. 121, 105626, 2022. Impact Factor-5.307, Citescore-7.1.

·       Das A., Agarwal P., Jain G. K., Aggarwal G., Lather V., Pandita D. Repurposing Drugs as Novel Triple-negative Breast Cancer Therapeutics. Anti-Cancer Agents in Medicinal Chemistry. 22 (3), 515-550, 2022. Impact Factor- 2.527, Citescore-4.0.

 

Dr. Vikesh Kumar Shukla

Dr. Shukla is leading a group of about 09 postgraduate and 04 doctorate students, in various areas of Pharmaceutics and DRA like pre-formulation profiling, solid state characterization, improvement of aqueous solubility and drug regulatory affairs. Dr. Shukla holds a masters (2006) and doctorate degree (2011) in Pharmacy from KLES’ college of Pharmacy, Belgaum, Karnataka/RGUHS. In Industry, Dr. Shukla transferred technology from F&D to the production floor for products like suspension for reconstitution and oral liquid suspension. Dr. Shukla has developed expertise in characterization and stabilization of the amorphous form, polymorphism, formulation, nanocrystalline solid dispersion, improvement of oral bioavailability and drug regulatory affairs. Dr. Shukla’s lab has been developing technologies to improve delivery of ‘difficult-to-deliver’ drug molecules in the areas of nano-formulations, solid dispersions and SNEDDS. Dr. Shukla is actively engaged in the study of regulatory and legislative research for the timely launch of new and generics products in the domestic and international market.

Previously, He received Senior Research Fellowship from ICMR, New Delhi during Ph.D Studies and was awarded Summer Teacher research Fellowship, INSA, AICTE Seminar grant, New Delhi, Best Teacher award and several other awards and recognitions. He had authored several research and review papers and actively reviewed research/reviews articles for several national and international journals. He has presented many research papers in various national and international Conferences/ Seminars. He is a life member of PCI, APTI, IPGA and CRS, USA.

 

RESEARCH INTERESTS

  • Design and characterization of nanocrystalline solid dispersion,
  • Preformulation and stability studies on amorphous form, polymorphism, improvement of oral bioavailability
  • Regulatory and legislative research for the timely launch of new and generics products in the domestic and international market.

SELECTED PUBLICATIONS

1

G Khosla, V Sharma, Vikesh Shukla *, et.al., (2024). Bioactive Molecule-Based Nano-Particulate Drug Delivery System For Antifertility Activity Journal of Dispersion Science and Technology LDIS, Taylor & Francis, 1-14, April-2024. https://doi.org/10.1080/01932691.2024.2339455

2

Katrolia, A., Chauhan, S.B., Shukla, V.K. * et  al, Formulation and evaluation of Metformin Hydrochloride-loaded Curcumin–Lycopene Niosomes. SN Applied Sciences , Spinger nature Journal , 2019, 1(12), 1703. DOI: 10.1007/s42452-019-1768-6

3

PK Sharma, VK Shukla*, A Kumar et al. Physical Characterization and In Vitro Evaluation of Dissolution Rate from Cefpodoxime Proxetil Loaded Self Solidifying Solid SNEDDS, Current Drug Delivery (Bentham Science Journal):19(3); 395-406

DOI: 10.2174/1567201818666210805153859

4

Suryawanshi, S.J., Jain, S., Sharma, R.K., ...Shukla, V.K., Sharma, N. Current veterinary regulations and way ahead: Research in Veterinary Science, 2024, 166, 105101

DOI: 10.1016/j.rvsc.2023.105101

5

Mishra, S., Shukla, V.K*. et al, Quality management and US regulatory auditing guidelines for medical device manufacturers Health and Technology, 2021, 11(4), pp. 733–744

DOI: 10.1007/s12553-021-00566-2

 

Prof. (Dr.) Maryam Sarwat

Professor

  • Ph.D. from Jamia Hamdard University
  • Postdoctoral Research from United Nation’s (UN) Organization ‘International Centre for Genetic Engineering and Biotechnology (ICGEB)’.
  • Recognized as Path breaking Scientist of Amity University, NOIDA in 2024.
  • Published 61 papers in international journals, Cumulative impact factor is 232.
  • Published 9 books with international publishers Elsevier-UK, Springer Nature Germany, Taylor and Francis and King Abdul Aziz University, Jeddah.
  • Published 24 book chapters in International Books
  • International Resarch Collaborations with University of Texas, USA, University of Illinois, USA; Ege University, Turkey; ITMO University, Russia; King Abdul Aziz University, Jeddah; King Saud University, Riyadh.
  • Total citations of my publications: 3800.
  • h-index is 26 and i-10 index is 41.
  • Presented research work in international conferences at Prague, Germany, and France (Paris and Versailles).
  • Got travel assistantship from Government of India (DST, DBT, SERB, INSA, CSIR), Amity University, International Agencies (Society of Experimental Biology, UK and United Scientific Group, USA).
  • Included in Top 100 Most Influential Muslim Women of Uttar Pradesh by Rising Beyond The Ceiling (RBTC 2023).
  • Included in the Top 2% Scientist of the World (for 2022 and 2023) by Stanford University, UK and Elsevier BV.
  • Best Oral Presentation Award for Research Presentation in DBT, SERB and CSIR sponsored International Conference on Advances in Biotechnology (ICAB 2023) at Amity University, Mum bai
  • Scientist of the Year award by National Environment Science Academy (NESA).
  • Vice Chancellor’s Merit Scholarship.
  • Nominated for Dr. C. R. Krishnamurthy Young Scientist Award.
  • DBT, Govt. of India Post-doctoral Fellowship (July 2007-Aug2010)
  • DBT, Govt. of India JRF (2001-2003)
  • Guiding 7 Ph.D. students, one postdoctoral student and successfully guided 12 Master students for research thesis.
  • Filed five patents on herbal drugs and their use to cure human diseases like liver cancer, obesity, neurodegeneration and bone regeneration.
  • Successfully completed four research projects from DBT, SERB and AYUSH as Principal investigator (PI) worth 1 crore, 23 lakh rupees.
  • Three  ongoing research projects from Govt. of India (1 crore rupees).
  • Guest editor of the special issue for Current Pharmaceutical Design (Impact Factor 3.2) and Seminars in Cell and Development Biology (Impact Factor 7.7).
  • Reviewer and editorial board member of more than 15 international journals.

 

RESEARCH INTERESTS

  • Phytopharmaceuticals
  • Anticancer, neuroprotective, bone regeneration
  • Molecular mechanism

SELECTED PUBLICATIONS

  • Gupta M, Nimesh H, Bilgrami AL, Sarwat M (2024) A saffron based polyherbal formulation DuK prevents hepatocellular carcinoma in male wistar rats. Curr Cancer Drug Targets. 2023 Aug 18. doi: 10.2174/1568009623666230818115905. PMID: 37594101. Impact Factor 3.0
  • Sharma N, Gupta M, Nabi G, Biswas S, Ali S, Maryam Sarwat (2023) Variation in the anticancer, antioxidant and antiobesity potential of different polarity extracts of saffron petals. 3 Biotech. 13(7):249. Springer. Impact Factor 2.9. 10.1007/s13205-023-03669-x.
  • M Gupta, D Singh, S Rastogi, HR Siddique, N Al-Dayan, A Ahmad, Sikander M, Maryam Sarwat (2023) Anti-cancer activity of guggulsterone by modulating apoptotic markers: a systematic review and meta-analysis. Frontiers in Pharmacology 14: 1155163. doi: 10.3389/fphar.2023.1155163. Impact Factor 5.9
  • Meenakshi Gupta, Kumari Chandan, Maryam Sarwat (2022) Natural products and their derivatives as Immune Check Point Inhibitors: Targeting cytokine/chemokine signalling in Cancer. Seminars in Cancer Biology. Impact Factor 17. S1044-579X (22) 00153-5. doi: 10.1016/j.semcancer.2022.06.009.
  • Namgyal D, Ali S, Mehta R, Sarwat M (2020) The Neuroprotective effect of curcumin against Cd-induced neurotoxicity and hippocampal neurogenesis promotion through CREB-BDNF signaling pathway. Toxicology 442: 15242. Elsevier. doi:10.1016/j.tox.2020.152542. Impact Factor 4.2. ISSN: 0300-483X.

 

Prof. (Dr.) Rajeev Kharb

Professor

Dr. Rajeev Kharb, who completed his M. Pharmacy in Pharmaceutical Chemistry and Ph.D., joined the Amity Institute of Pharmacy at Amity University Uttar Pradesh, Noida on March 1, 2017. With 19 years of teaching and research experience, along with 1 year in the industry, he holds a robust 20-year career in the field.

Dr. Kharb has an impressive publication record, with 45 research papers and review articles in esteemed international journals, as well as 7 books to his name. He has successfully supervised 20 M. Pharmacy students and one Ph.D. scholar and is currently mentoring four Ph.D. scholars.

In recognition of his work, Dr. Kharb received an international travel grant from the Science and Engineering Research Board (SERB) - International Travel Support (ITS) program of the Department of Science and Technology (DST), Government of India. This grant facilitated his presentation of a research paper at the prestigious IUPAC International Symposium on Bioorganic Chemistry (ISBOC-11) and the Konstanz Symposium on Chemical Biology, held from September 27-29, 2017 at the University of Konstanz, Germany.

 

RESEARCH INTERESTS

  • Docking Studies
  • Synthesis of heterocyclic compounds
  • Antimicrobial activity

SELECTED PUBLICATIONS

«  Kapil Kumar Goel, Afzal Hussain, Mohammad A Altamimi, Satyendra Kumar Rajput, Prince Prashant Sharma, Rajeev Kharb, Wael A Mahdi, Syed Sarim Imam, Sultan Alshehri, Osamah Abdulrahman Alnemer, Anu Chaudhary. Identification of Potential Antitubulin Agents with Anticancer Assets from a Series of Imidazo[1,2-a]quinoxaline Derivatives: In Silico and In Vitro Approaches. Molecules, 2023; 28(2): 802.

«  KK Goel, S Thapliyal, R Kharb, G Joshi, A Negi, B Kumar. Imidazoles as Serotonin Receptor Modulators for Treatment of Depression: Structural Insights and Structure–Activity Relationship Studies. Pharmaceutics, 2023; 15(9):2208.

«  Kapil Kumar Goel, Satyendra Kumar Rajput, Prince Prashant Sharma, Monalisa Mukherjee, Rajeev Kharb. Design, Synthesis and Biological Evaluation of 2-Phenylquinazolin-4-yl 4-Methylbenzenesulfonate Derivatives as Anticancer Agents via Tubulin Inhibition. Synlett, 2023; 34(1): 49-56.

«  Rajeev Kharb. Updates on receptors targeted by heterocyclic scaffolds: New horizon in anticancer drug development. Anti-Cancer Agents in Medicinal Chemistry 2021, 21(11): 1338-1349.

Rajeev Kharb, Kashif Haider, Kumari Neha, Mohammad S. Yar. Aromatase inhibitors: Role in postmenopausal breast cancer.  Archiv der Pharmazie, 2020; 353(8), 2000081.

Prof. (Dr.) Ramanpreet Walia

Professor

Dr. Walia, Doctorate in Pharmaceutical sciences, completed her M. Pharmacy in Pharmaceutical Chemistry from Panjab University Chandigarh. She has been associated with Amity since 2017.  She has a total 21 years of teaching and research experience, along with 1.5 year in the industry

 

She published 35 papers in esteemed international journals including review and research articles and 3 book chapters. She also filed 2 patents. She has successfully supervised fourteen M. Pharm students and one Ph.D. scholar and is currently guiding four Ph.D. scholars.

 

She has also delivered oral talk in many National and International Conferences (Dubai, Türkiye etc) on topics of IPR (Intellectual Property Right) and Entrepreneurship apart from her core research

Some of her professional Achievements are

•              Registered Patent Agent by GOI (Registration No -2700)

•              Trained in IPR by Women Scientist scheme WOS-C conducted by TIFAC, under DST, GOI 

•              Certification by WIPO on “The result list in Patentscope” in 2020

•              Entitled as IP Facilitator in the - List of facilitators for patent and designs since 2019

•              Awarded as Training of Trainers in IPR by CIPAM under TIFAC (DST, GOI) in Feb 2018

•              North zone coordinator IPGA women Forum

•              Trained and Certified in Entrepreneurship skills development

RESEARCH INTERESTS

«  Docking Studies

«  Synthesis of heterocyclic compounds

«  Anti Diabetic, Anti-Obesity and related disorders.              

«  Antimicrobial activity

Method Validation 

SELECTED PUBLICATIONS

  1. Arora, B., Lather, V., Pathalingappa, M. B., & Walia, R. (2024). Enhancement of aqueous solubility of hesperidin and naringenin utilizing hydrotropic solubilization technique: characterization and in vitro evaluation. Journal of Asian Natural Products Research, 1–12. https://doi.org/10.1080/10286020.2024.2358831
  2. Sahu N.;Alam P.;Ali A.;Kumar N.;Tyagi R.;Madan S.;Walia R.;Saxena S.Optimization, In Vitro and Ex Vivo Assessment of Nanotransferosome Gels Infused with a Methanolic Extract of Solanum xanthocarpum for the Topical Treatment of Psoriasis, Gels 2024, 10(2), 119; https://doi.org/10.3390/gels10020119
  3. Sahu N, Madan S*, Walia R, Tyagi R, Fantoukh OI, Hawwal MF, Akhtar A, Almarabi I, Alam P, Saxena S. Multi-target mechanism of Solanum xanthocarpum for treatment of Psoriasis based on network pharmacology and molecular docking. Saudi Pharmaceutical Journal. 2023 Sep 16:101788. IF: 4.5
  4. Narang M , Kaul U , West N , Kher S , Walia R , A position statement on the use of intravascular imaging in India, Journal of Applied Pharmaceutical Science Vol. 12(10), pp 001-010, October, 2022,  DOI: 10.7324/JAPS.2022.121001
  5. Pandey N, Jain GK, Thakkar AR, Walia R. Quality and regulation standards for positron emission tomography equipment and bone marrow cell separator as medical devices in India. Asian J Pharm Res Health Care 2022;14:79-83., DOI: 10.4103/ajprhc.ajprhc_11_21

 

Prof. (Dr.) Neerupma Dhiman

Dr. Neerupma Dhiman, completed her M. Pharmacy in Pharmaceutical Chemistry from UIPS, Panjab University and Ph.D. from ACBR, University of Delhi. During PhD, she was the recipient of Senior Research Fellowship (SRF) from Indian Council of Medical Research (ICMR) for Ph.D. work. She joined the Amity Institute of Pharmacy at Amity University Uttar Pradesh, Noida on December 7, 2009. She has rich experience of 20 years of teaching and research. She has 32 research papers and review articles in esteemed international journals, and 4 book chapters. She has successfully supervised 10 M. Pharmacy students and 6 Ph.D. scholars and is currently mentoring 4 Ph.D. scholars. To further strengthen her research work she has 3 filed, 2 published and 3 granted patents in her name. She has completed one AYUSH project as Co-PI and 2 Industrial projects. Her contributions to pharmaceutical sciences have been recognized by getting the IPGA Fellowship Award, awarded in August 2019 at Kolkata. Dr. Neerupma is a lifetime member of the Indian Pharmaceutical Graduate Association (IPGA) and Society of Pharmaceutical Education and Research (SPER) She has actively participated and presented her research at various national and international conferences held in India.

RESEARCH INTERESTS

Medicinal Chemistry, natural chemistry, Synthesis of organic compounds, semisynthetic derivatives of natural compounds, molecular docking.

SELECTED PUBLICATIONS

  1. V Tomar, N Kumar, R Tomar, D Sood, N Dhiman, SK Dass, S Prakash, Biological evaluation of noscapine analogues as potent and microtubule-targeted anticancer agents. Scientific reports 9 (1), 19542. IF 4.2
  2. N Dhiman*, R Awasthi, B Sharma, H Kharkwal, GT Kulkarni. Lipid nanoparticles as carriers for bioactive delivery. Frontiers in chemistry 9, 580118. (2021) IF 3.8
  3. G Ahmad, SA Mir, LK Anand, FH Pottoo, N Dhiman*, F Malik, A Ali. Myricanol-9-acetate, a novel naturally occurring derivative of myricanol, induces ROS-dependent mitochondrial-mediated Apoptosis in MCF-7 cancer cells. Current Topics in Medicinal Chemistry 21 (15), 1418-1427. (2021) IF 4.8
  4. S. Chander, G.T. Kulkarni, N. Dhiman, H. Kharkwal. Protein Based nanohydrogels for Bioactive Delivery. Frontiers in Chemistry. 9 (2021) IF 3.8
  5. Ahmad, G., Hassan, R., Dhiman*, N., Ali, A. Assessment of Anti-inflammatory Activity of 3-Acetylmyricadiol in LPS-Stimulated Raw 264.7 Macrophages Combinatorial Chemistry and High Throughput Screening, 2022, 25(1), pp. 204–210. IF 1.8
  6. Sundram, S., Dhiman, N., Malviya, R. and Awasthi, R., 2024. Non-coding RNAs in Regulation of Protein Aggregation and Clearance Pathways: Current Perspectives Towards Alzheimer's Research and Therapy. Current Gene Therapy, 24(1), pp.8-16. IF 4.2

 

Prof. (Dr.) Nitin Sharma

Professor & Centre Head

Dr. Nitin Sharma is completed Phd from Jawaharlal Technological University, Hyderabad and undergone postdoc research in Institute of Nuclear Medicine and Allied Sciences (INMAS), New Delhi. His scholarly contributions have been recognized through the receipt of three research grant 1.SERB post doctoral fellowships (as PI, 19.2 lakh), AYUSH research grant (as PI, Rs.22.41 lakh) and SERB Core research grant (as Co-PI, Rs 26.16 lakh). With over 65 research publications in esteemed national and international journals, Dr. Sharma has demonstrated a commitment to advancing pharmaceutical sciences. Moreover, his inventive skill is evident in the filing of six Indian patents, including a groundbreaking invention in handwash manufacturing and dispensing technology, which gathered widespread attention in leading national newspapers. Dr. Sharma's impact extends beyond academia, as evidenced by his successful execution of industrial projects exceeding a value of 40 lakh. Additionally, his involvement as a council member of the Indian Pharmaceutical Association, Delhi State Branch, underscores his dedication to fostering collaboration and innovation within the pharmaceutical community.

 

RESEARCH INTERESTS

  • Drgu targeting through novel and conventional delivery system for oral and brain related disorders
  • Natural polysaccharide based drug delivery
  • Gamma Scintigraphy based clinical investigation on animal and human

SELECTED PUBLICATIONS

«  Sharma N, Kurmi BD, Singh D, Mehan S, Khanna K, Karwasra R, Kumar S, Chaudhary A, Jakhmola V, Sharma A, Singh SK, Dua K, Kakkar D. Nanoparticles toxicity: an overview of its mechanism and plausible mitigation strategies. J Drug Target. 2024 Jun;32(5):457-469.

«  Sharma N, Khanna K, Kumar N, Karwasra R, Janakiraman AK, Rajagopal MS. Illuminating Insights: Clinical Study Harnessing Pharmacoscintigraphy for Permeation Study of Radiolabeled Nimesulide Topical Formulation in Healthy Human Volunteers. Assay Drug Dev Technol. 2023 Oct;21(7):325-330.

«  Sharma A, Sharma N, Singh S, Dua K. Review on theranostic and neuroprotective applications of nanotechnology in multiple sclerosis, Journal of Drug Delivery Science and Technology. 81.2023. 104220.

«  Prasher P, Sharma P, Mehta M, Satija S, Sharma N, Current status and application of polysaccharide in drug delivery systems. Colloid and Interface Science Communications.42. 2021. 100418.

Kumar M, Nishad DK, Kumar A, Bhatnagar A, Karwasra R, Khanna K, Nair K, Sharma D, Dua K, Mudaliyar V, Sharma N. Enhancement in brain uptake of Vitamin D3 nanoemulsion for treatment of cerebral ischemia: Formulation, Gamma scintigraphy and efficacy study in transient middle cerebral artery occlusion rat models. Journal of Microencapsulation.2020;37:1-10

Dr. Archana Sharma

Associate Professor

Dr. Archana Sharma completed her Ph.D. from Biochemical Engineering and Food Technology department, H.B.T.I., Kanpur university in 1994 and joined industries like Quality manager-Kissan Annapurna Atta-Hindustan Lever, Quality Manager-Esscee Biotech (India) Pvt. Ltd.-Toal export house in DNA, RNA intermediates and Scientist Ecoman Laboratories-Environmental testing house from 1994-2007 as team lead in several projects. Then joined Amity University as faculty-Amity Institute of Pharmacy in 2007 to till date. Total 31 years' experience in research, Industry and academics.

Dr. Archana Sharma has 25 research papers and review articles in esteemed international & National journals, as well as 2 books and 4 book chapters and 2 filed patents to her name. Dr. Archana Sharma is a lifetime member of the Society of Pharmaceutical Education and Research (SPER) and UPASTA.

A Good Background of analytical science & Quality Control of Water, Food Products, pesticides & biotechnological products (DNA& RNA intermediates).

Aware about Quality assurance aspects like 5S, G.L.P., G.M.P., T.P.M., H.A.C.C.P., etc.

 

RESEARCH INTERESTS

«  Synthesis of natural products

«  Antimicrobial, Antidiabetic and other activities

Quality control testings including Karl-Fischer, BOD, COD, HPLC, GC, UV, Nephelometer, Flame Photometer, pH meter, EC meter, Production and testings of HPLC and Ancillary reagents.

SELECTED PUBLICATIONS

  • Synthesis and Evaluation of Antiepileptic Activity of Newly Designed Coumarin-Sulfonamide Hybrids. ARTI GUPTA1,2, , SANDEEP KUMAR3, , VIJAY KUMAR SINGH4, , B.P.MALLIKARJUN5, , NEERUPMA DHIMAN1,*, and ARCHANA SHARMA1,* Asian Journal of Chemistry; Vol. 33, No. 12 (2021), 3108-3114.
  • d '3D-QSAR, E-pharmacophore and molecular docking to explore substituted sulfonamides as carbonic anhydrase inhibitors in epilepsy' Author by Arti Gupta, Viney Lather, Dushyanth R Vennapu, Sandeep Kumar, Mallikarjun. B.P., Neerupma Dhiman, Archana Sharma, Research Journal of Pharmacy and Technology Paper ID:21121130947610112.
  • Drugs For AIDS, S. Ray, Z. Fatima & A. Saxena, Medicinal Chemistry, 2010,10,147-161.
  • Phytoestrogen "Genistein": Its extraction & isolation from soybean seeds., Jyoti, S.S. Agrawal, Shikha Saxena, Archana Sharma, International Journal of Pharmacognosy & Phytochemical Research 2015, 7(6),1121-1126.
  • Locked nucleic acid-A cancer therapeutic agent., Archana Sharma, Gunjan Sharma, International Journal of Advanced research, 2,4,136-148.

 

Dr. Swati Madan

Associate Professor

Dr. Swati Madan, Doctorate in Pharmacognosy & Phytochemistry from Central Indian Pharmacopeial Laboratory, Indian Pharmacopoeia Commission, (I.P.C), Govt. of India, Ghaziabad. She has completed her M. Pharmacy in Pharmacognosy & Phytochemistry, from Jamia Hamdard University, New Delhi. She has been associated with Amity since 2010.  She has a total 20 years of teaching and research experience, along with 1.5 year in the industry.

 

She has published 55 papers in esteemed international journals including review and research articles and 7 book chapters. She also filed 1 patent. She has successfully supervised twelve M. Pharm students.

She has successfully guided 06 Ph.D. students and currently guiding 3 Ph.D. student

Total citations of publications: 867

h-index is 15 and i-10 index is 20.

Successfully completed three research projects from EMR AYUSH, CCRUMs as Principal investigator (PI) worth 27 lakh rupees.

One ongoing research project from NMPB, AYUSH, Govt. of India.

 

RESEARCH INTERESTS

  • Phytopharmaceuticals
  • Standardization, Extraction, Isolation, Nanoformulation of Herbal drugs
  • Antidiabetic, Anticancer

 

SELECTED PUBLICATIONS

Ø  Satyendra K. Rajput1 *, Vishal Kumar Dubey2, Shalini Singh1 and Swati Madan3 (2024) Bartogenic Acid: A Promising Penatacyclic Triterpenoid in Cancer Research and Possible Mechanism. Journal of Cancer Science & Therapy, Volume 16:01, pg 1-4. IF:2.06

Ø  N Sahu, P Alam, A Ali, N Kumar, R Tyagi, R Walia, S Madan, S, Saxena (2024).  Optimization, In Vitro and Ex Vivo Assessment of Nano transferosome Gels Infused with a Methanolic Extract of Solanum xanthocarpum for the Topical Treatment of Psoriasis. Gels, 10(2), 119, 1-22 IF: 5.2

Ø  Rama Tyagi1, Ayesha Waheed 2, Neeraj Kumar 3, Abdul Ahad 4, Yousef A. Bin Jardan 4 , Mohd. Mujeeb3, Ashok Kumar5, Tanveer Naved1 and Swati Madan1* (2023). Formulation and Evaluation of Plumbagin-Loaded Niosomes for an Antidiabetic Study: Optimization and In Vitro Evaluation. Pharmaceuticals IF 4.6

Ø  Sahu N, Madan S*, Walia R, Tyagi R, Fantoukh OI, Hawwal MF, Akhtar A, Almarabi I, Alam P, Saxena S. Multi-target mechanism of Solanum xanthocarpum for treatment of Psoriasis based on network pharmacology and molecular docking. Saudi Pharmaceutical Journal. 2023 Sep 16:101788. IF: 4.5

Tyagi R, Waheed A, Kumar N, Ahad A, Mujeeb M, Naved T, Madan S*. Application of Box–Behnken design for the optimization of Plumbago zeylanica extract-loaded niosomes: preparation, characterization and in vitro antidiabetic and antioxidant activity. Journal of Dispersion Science and Technology. 2023 Sep 5:1-5. IF:2.0

Dr. Kalpana Nagpal

Dr. Kalpana Nagpal completed B.Pharm (2003-07; Gold Medalist), M.Pharm (2007-09; Gold Medalist) and regular PhD from Guru Jambheshwar University of Science and Technology , Hisar as Sir CV Raman Scholar and worked with Lovely Professional University, Punjab (September 2013-November 2014) and Apeejay Stya University, Haryana (01 December 2014-13 March 2017) and Joined Amity University on March 14, 2017 as Assistant Professor-III and was promoted to Associate Professor (December, 2021 to at present). Her core research area is the novel drug delivery formulation development for the treatment of various diseases like neurological disorders, wound healing, cancer, psoriasis, etc. She has published more than 50 research and review papers and many of them are published in Q1 and Q2 journals of Thomson Reuters, accumulating a total impact factor above 100. She is serving as editorial board member and reviewer of international journals of repute. She has authored three books and six book chapters. She is serving as subject expert for examination of UG, PG and PhD program of various National and International Universities. For recognition of her research contribution, she was awarded the Haryana Yuva Vigyan Ratan Award for the Year 2021 by Department of Science and Technology, Haryana. She actively organizes various national and international conferences and not only her but her students' bagged prizes for presenting her lab research work in various such events. She got an international travel grant (ITS) from DST to present her research at AAPS Pharm Sci 360, Texas (USA) in 2019.  She is selected as the member of Indian National Young Academy of Science (INYAS) 2022-2027 member. As a member of INYAS, she has conducted more than 25 science outreach activities for the students and teachers of rural and urban areas of India. In the year 2022, she was listed among the Top 75 Women Leaders of India in STEAM by Principal Scientific Advisor, government of India and Red Dot foundation on Azadi Ka Amrit Mahotsav, 75 years of India’s Independence. At present, she has an international funding of USD 18800 as PI (Principal Investigator) for a project in collaboration with Indian, South Africa and Nepal.

 

RESEARCH INTERESTS

«  Design and development of drug delivery system for better brain uptake

«  Chitosan based nano formulations for better therapeutic effects

«  Phytoconstituent based formulation development

UV based analytical method development for API quantitative estimations

SELECTED PUBLICATIONS

«  Ellagic acid-loaded, tween 80-coated, chitosan nanoparticles as a promising therapeutic approach against breast cancer: In-vitro and in-vivo study. Life Sciences 284, 119927

«  Minocycline encapsulated chitosan nanoparticles for central antinociceptive activity, International Journal of Biological Macromolecules, 72, 2015, 131-135

«  Optimization of brain targeted gallic acid nanoparticles for improved antianxiety-like activity, International Journal of Biological Macromolecules, 57, 2013, 83-91

«  Formulation of Itraconazole Loaded Clove Oil based Nanoemulsion using Pseudoternary Phase Diagram for Improved Thermodynamic Stability. Indian Journal of Pure & Applied Physics (IJPAP) 62 (2), 124-132

Targeting keratinocyte hyperproliferation, inflammation, oxidative species and microbial infection by biological macromolecule-based chitosan nanoparticle-mediated gallic acid–rutin combination for the treatment of psoriasis. Polymer Bulletin. 77, 4713–4738 (2020).   

Dr. Dheeraj Nagpal

Associate Professor

Dr. Dheeraj Nagpal completed Phd in Pharmaceutical Sciences from Amity university and is currently working as an Associate Professor.  He has over 15 years of combined academic & industrial experience. Holding degrees in B.Pharm and M.Pharm (Pharmaceutics) from Jamia Hamdard, Hamdard University, New Delhi. He previously served as a Research Scientist at Dabur Research Foundation, focusing on Formulation Development in oncology. His expertise lies in conventional and novel drug delivery systems, notably liposomes and solid lipid nanoparticles. Dr. Nagpal has authored over 14 papers in various national and international journals and actively participates in conferences, delivering technical sessions.

 

RESEARCH INTERESTS

«  conventional and novel drug delivery systems

Solid Lipid Nanoparticles

SELECTED PUBLICATIONS

  • Evaluating the synergistic effect of Mucuna prurines extract and sesame oil against the Parkinson’s disease zebrafish model: in-vivo/in-silico approach;N Dogra, D Nagpal, V Aeri, S Ahmad, D Pande Katare; All Life 14 (1), 1022-1042.

 

  • Exploring the Synergistic Effect of Thymol with Oxacillin against Methicillin Resistant Staphylococcus aureus;HK Sharma, A Karna, SK Verma, P Gupta, D Nagpal, A Kumar, D Pandita; Indian Journal of Microbiology, 1-10.
  • Virtual screening and antimicrobial evaluation for identification of natural compounds as the prospective inhibitors of antibacterial drug resistance targets in Staphylococcus;VL Hitesh K Sharma, Puneet Gupta, Dheeraj Nagpal, Monalisa Mukherjee; Fitoterapia 168.

 

  • Evolution of solid dispersion technology: solubility enhancement using hydroxypropyl methylcellulose acetate succinate: myth or reality;NR Babu, D Nagpal, D Ankola, R Awasthi; Asay and Drug Development Technologies 20 (4), 149-163.

 

Dr. Shikha Baghel Chauhan

Associate Professor

Google Scholar: https://scholar.google.co.in/citations?user=0L9aK6YAAAAJ&hl=en

Scopus ID: https://www.scopus.com/authid/detail.uri?authorId=57191293287

Orcid ID: https://orcid.org/0000-0002-1569-213X

 

Educational Qualifications:

  • B.Pharm (2004, Delhi Institute of Pharmaceutical Sciences and Research 

(DIPSAR), Delhi University)

  • M. Pharm (2006, IIT-BHU Banaras Hindu University)
  • PhD  (Amity University, Noida),

 

Experience: Total of 18 years of National/International research (Industrial and Academic) experience in   Pharmaceutical Sciences (Formulation and  Development). Guided 28 M. Pharm scholars.

 

Research Areas: Novel Drug Delivery systems, Artificial Intelligence, Transdermal Drug Delivery systems, Herbal Drug Development, Nanoparticles, Nanolipid carriers.

 

a.Publications, Awards, Achievements:

  • More than 50 National and International publications, Authored 13 Books with national and International publishers, published 12 book chapters in books published by International publishers. 2 Patents Granted.

 

 

 

Research Grants: a. Co-PI Project Title: Selenium conjugated andrographolides and their role and molecular mechanism as new therapeutics in hepatic cancer.Funded by DST- SERB.

 

  • All India GATE Rank – 42 (99.42 percentile)

 

  • PROCTORIAL BOARD MEMBER AT UNIVERSITY ( 2014-2016)

 

  • Anti Ragging committee and Disciplinary Committee Coordinator

 

RESEARCH INTERESTS

Artificial Intelligence in Pharmaceutical Development, Nanolipid carriers, Nanoparticles, Hydrogels

SELECTED PUBLICATIONS

  • Singh, S.; Chauhan, S.B.; Gupta, C.; Singh, I.; Gupta, A.; Sharma, S.; Kawish, S.M.; Rahman, S.; Iqbal, M. Design and Characterization of Citronella Oil-Loaded Micro-Emulgel for the Treatment of Candida Albicans Infection. Gels 2023, 9, 799. https://doi.org/10.3390/gels9100799
  • Singh, S., Khurana, K., Chauhan, S.B. and Singh, I. (2023) 'Emulsomes: new lipidic carriers for drug delivery with special mention to brain drug transport', Future Journal of Pharmaceutical Sciences, 9(1).
  • Shikha Baghel Chauhan, Kumaraswamy Gandla, Gudas Ganesh Kumar, MD.Parveen, and Swalin Parija. “FORMULATION AND EVALUATION OF NEOMYCIN SULFATE HYDROGELS FOR WOUND HEALING”. Journal of Pharmaceutical Negative Results, Sept. 2022, pp. 234-53, doi:10.47750/pnr.2022.13.S01.30.
  • Shikha Baghel Chauhan, Kumaraswamy Gandla, “Formulation and evaluation of Orodispersible tablets for the treatment of Hypertension” High Technology Letters, Volume 28, Issue 9, 2022.
  • Amisha Chauhan, Shikha Baghel Chauhan and Sakshi Nainwani, The Review on Cosmetic Regulation-Quality Education, ECS Transactions (2022) ,Volume 107, 241-247
  • A. Katrolia, S. B. Chauhan and V. K. Shukla., Formulation and evaluation of Metformin Hydrochloride-loaded Curcumin–Lycopene Niosomes. SN Applied Sciences (2019) 1:1703.

 

Dr. Alka Lohani

Associate Professor

Dr. Alka Lohani is working as Associate Professor at Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India. She obtained her B.Pharm and  M.Pharm degree in Pharmacy (Pharmaceutics) from Kumaun University, Nainital, Uttarakhand, India, and her Ph.D. in Pharmacy from IFTM University, Moradabad (U.P), India. Her area of research expertise is dermatology, development of cosmetic formulations, transdermal drug delivery systems, nanotechnology, and polymer-based drug delivery systems. Dr. Alka has gained international recognition and prestigious grants, including the IBRO-International Travel Grant to attend Neuroscience schools in Nepal (2024) and Hyderabad (2022). Her research excellence was acknowledged at the IBRO Neuroscience School Nepal-2024, where she received the 'Best Dream Project' award for her outstanding project. With over 12 years of teaching and research experience, Dr. Alka has made significant scholarly contributions. She has authored more than 30 research articles published with renowned international publishers like Elsevier, Wiley Publishers, Taylor and Francis, Hindawi, and MDPI. Dr. Alka has edited 2 books and published several book chapters with Elsevier, Nova publisher and Apple Academic Press. In addition, she holds three patent publications and one design patent. She serves as a reviewer for various prestigious journals including the Journal of Cosmetic Dermatology, Cosmetics, Molecules, International Journal of Dermatology and Venereology, and Naunyn-Schmiedeberg’s Archives of Pharmacology.

 

RESEARCH INTERESTS

«  Nanotechnology based drug delivery systems

«  Transdermal drug delivery

«  Cosmetics and cosmeceuticals

Polymer based drug delivery systems

SELECTED PUBLICATIONS

«  Alka Lohani, Mohit Maurya, Sushil Kumar, Navneet Verma. IPN beads prepared by tailoring of cassia tora gum and sodium carboxymethyl cellulose using Al+++ for controlled drug delivery. Journal of Drug Delivery Science and Technology. 2023;81:104308.

«  Alka Lohani, Pierfrancesco Morganti. Age-Defying and Photoprotective Potential of Geranium/Calendula Essential Oil Encapsulated Vesicular Cream on Biochemical Parameters against UVB Radiation Induced Skin Aging in Rat. Cosmetics. 2022; 9:1-13.

«  Alka Lohani, Anurag Verma, Hema, Kamla Pathak. Topical Delivery of Geranium /Calendula Essential Oil Entrapped Ethanolic Lipid Vesicular Cream to Combat Skin Aging. BioMed Research International. 2021:1-13.

«  Alka Lohani, Arun Kumar Mishra, Anurag Verma. Cosmeceutical potential of geranium and calendula essential oil: Determination of antioxidant activity and in vitro sun protection factor. Journal of Cosmetic Dermatology. 2019;18:550-557.

Alka Lohani, Garima Singh, ShivSankar Bhattacharya, Rahul Rama Hegde, Anurag Verma. Novel tailored-interpenetrating polymer network beads of κ-carrageenan and sodium carboxymethyl cellulose for controlled drug delivery. Journal of Drug Delivery Science and Technology. 2016; 31: 53-64.

Dr. Annie Gupta

Assistant Professor - III

Dr. Annie Gupta is a seasoned research professional with over a decade of experience in plant metabolomics, medicinal chemistry, and analytical chemistry. She did her M. Pharm in medicinal chemistry and earned her Ph.D. in Medicinal Chemistry from CSIR-NBRI, Lucknow, under the aegis guidance of Principal Scientist Dr. OP Sidhu, focusing on HPLC, GC-MS, and NMR-based metabolomics. With 7 years of research experience at CSIR-NBRI and CSIR-CDRI, she has expertise in GC-MS and NMR-based metabolomic analysis of plant extracts and human biofluids.In addition to her research acumen, Dr. Gupta has been involved in proof-of-concept clinical studies, claim endorsements, and gamma scintigraphy for many Pharmaceutical Industries. Has been actively engaged in carrying out various industrial R&D consultancy with various pharma industries like Cadilla , Sun Pharma, Patanjali , Alkem etc.Dr. Annie Gupta qualified for the Graduate Aptitude Test for Engineers (GATE) in Pharmacy in 2009, conducted by IIT Roorkee, and pursued her M.Pharm. on a GATE Fellowship from 2009 to 2011. She again qualified GATE in 2013, conducted by IISc Bangalore. She has published more than 15 high-impact scientific research papers and filed one patent. Currently, she is at Amity University, contributing to department of Medicinal chemistry at AIP through her research and teaching.

 

RESEARCH INTERESTS

«  Phytochemistry

«  GC-MS and NMR-based metabolomics analysis of small molecules from plant extracts and human biofluid samples.

Phytopharmaceuticals, Gamma Scintigraphy

SELECTED PUBLICATIONS

«  Gupta, Annie, et al. "Unraveling Compositional Study, Chemometric Analysis, and Cell-Based Antioxidant Potential of Selective High Nutraceutical Value Amaranth Cultivars Using a GC-MS and NMR-Based Metabolomics Approach." ACS omega 8.50 (2023): 47573-47584. xx

«  Singh, S., Chauhan, S. B., Gupta, C., Singh, I., Gupta, A., Sharma, S.,& Iqbal, M. (2023). Design and Characterization of Citronella Oil-Loaded Micro-Emulgel for the Treatment of Candida Albicans Infection. Gels, 9(10), 799.

«  Gupta, A., Dahima, R., Panda, S. K., Gupta, A., Singh, G. D., Wani, T. A., ... & Rathore, D. (2024). QbD-Based Development and Evaluation of Pazopanib Hydrochloride Extrudates Prepared by Hot-Melt Extrusion Technique: In Vitro and In Vivo Evaluation. Pharmaceutics, 16(6), 764.

«  Ishrat, Nayab, Annie Gupta, Mohd Faheem Khan, Uzma Shahab, Mohd Shahnawaz Khan, Naved Ahmad, Kirtanjot Kaur, Saheem Ahmad, and Abbas Ali Mahdi. "Phytoconstituents of Nymphaea rubra flowers and their anti-diabetic metabolic targets." Fitoterapia 176 (2024): 106014.

Sharma, S., Gupta, P., Gupta, A., Kawish, S. M., Iqbal, Z., Vohora, D., & Kohli, K. (2023). Rapid Analytical Method Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Exemestane and Genistein with Specific Application in Lipid-Based Nanoformulations. ACS omega, 8(28), 25101-25113.

Dr. J.B. Senthil Kumar

Dr. JB Senthil Kumar completed his B.Pharm and M.Pharm (Pharmaceutical Chemistry) from JSS College of Pharmacy, Rocklands, Ooty, affiliated with TN Dr. MGR Medical University. He was awarded a GATE Scholarship from AICTE to pursue his M.Pharm. He then moved to Dr. BR Ambedkar Center for Biomedical Research (ACBR) at the University of Delhi, North Campus, as a Junior Research Fellow (JRF) in a DBT-funded project and subsequently registered for a Ph.D. in Medicinal Chemistry at the same institute. His Ph.D. was supported by national fellowships, including DBT-JRF (extramural) and CSIR-SRF, and he was awarded his Ph.D. degree in February 2014.

After earning his Ph.D., Dr. Kumar served as an Assistant Professor at KR Mangalam University, Delhi-NCR until 2018. He then received the prestigious Dr. DS Kothari Postdoctoral Fellowship for three years and joined the Special Centre for Molecular Medicine at Jawaharlal Nehru University, New Delhi. Following his fellowship, he worked at SIRO ClinPharm Pvt. Ltd in Mumbai for two years. After a successful two-year stint in industry, he transitioned to his current role as assistant professor at Center for Pharmaceutical Chemistry, Amity Institute of Pharmacy.

Dr. Kumar has published more than 10 international papers in reputed journals. His primary research interest is in developing, identifying, and optimizing small molecules from natural and synthetic sources to modulate biological functions and pathways for therapeutic benefits in neurological disorders, in particular Parkinson’s Disease.

 

RESEARCH INTERESTS

«  Development of multifunctional dopaminergic ligands for Parkinson’s disease

Development of natural products-like scaffolds   

SELECTED PUBLICATIONS

«  Kumar JBS, Kumari R, Luthra PM. Modulation of indole ring annulation in ergoline template: chemistry, receptor binding and in vivo pharmacology with 6-OHDA model of Parkinson’s disease. Med. Chem. Res. 2016; 25 (4)596-608.

«  Kumar JBS, Kumari N, Luthra PM. One-pot synthesis of 3, 4-dihydropyridin-2-one via Michael addition of in situ generated enaminones. Synth. Commun. 2013; 43(22), 3010- 3019.

«  Urvashi, Kumar JBS, Das P, Tandon V. Development of Azaindole Based Frameworks as Potential Antiviral Agents and Their Future Perspectives. J. Med. Chem. 2022;65,9,6454–6495.

«  Kumar JBS, Sharma B. A review on neuropharmacological role of erucic acid: an omega-9 fatty acid from edible oils. Nutr. Neurosci. 2020; 1-15.

Kumari R, Kumar JBS, Luthra PM. post-lesion administration of 7-NI attenuated motor and non- motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson's disease. Neurosci. Lett. 2015; 589: 191-195.

Dr. Sangeetha Gupta

Assistant Professor - III

Dr. Sangeetha Gupta earned her Master of Science (M.S.) in Pharmacology and Toxicology from the National Institute of Pharmaceutical Education and Research (NIPER), Mohali, in 2005, and her Ph.D. in Pharmacology from the All India Institute of Medical Sciences (AIIMS), New Delhi, in 2018. She joined the Amity Institute of Pharmacy at Amity University Uttar Pradesh, Noida Campus, on May 7, 2018.

Dr. Gupta has been recognized with several prestigious awards and fellowships, including an International Travel Grant by the Indian Council of Medical Research (ICMR) under International Travel Support for Non-ICMR Scientists in 2014. She was also awarded the DST-SERB Teachers Associateship for Research Excellence (TARE) (2020-2024), the Women Scientist Fellowship (WOS-A) (2014-2017), and the Senior Research Fellowship from ICMR (2010-2013).

In addition to her academic achievements, Dr. Gupta has industry experience as a Research Associate specializing in "Pain and Inflammation" at the Glenmark Research and Development Centre, Navi Mumbai, from 2005 to 2007.

 

RESEARCH INTERESTS

Preclinical studies

«  Stroke

«  Liver Cancer

«  Epilepsy

Pain and inflammation

SELECTED PUBLICATIONS

«  Singh A, Maryam S, Gupta S. Pharmacological Mechanism of Herbal Interventions for Bipolar Disorder. Current Pharmaceutical Design. Published on 05th June 2024. https://doi.org/10.2174/0113816128312442240519184440.

«  Gupta S, Sharma U. Chapter 48 - Intraluminal filament induced middle cerebral artery occlusion model of transient focal cerebral ischemia in rats. 2023, Pages 613-629. Handbook of Animal Models in Neurological Disorders, Academic Press. https://doi.org/10.1016/B978-0-323-89833-1.00052-5, Publication date: 2023/1/1. ISBN: 9780323898331

«  Arora S, Tagde P, Alam S, Akram W, Naved T, Gupta S. Influence of toll-like receptor-4 antagonist on bacterial load of asthma in Swiss albino mice: targeting TLR4/MD2 complex pathway. Environ Sci Pollut Res 30, 32854–32865 (2023). https://doi.org/10.1007/s11356-022-24521-4. Publication: 6/12/2022, Publisher: Springer Berlin Heidelberg. IF: 5.190; ISSN (online): 1614-7499.

«  Arora S, Alam S, Tagde P, Akram W, Kalonia H, Gupta S. TAK-242 Ameliorates Lipopolysaccharide-induced Lung Inflammation: Plausible Role of TLR-4 and TGF-β 21 (10), 801-809. YMER. Publication: Oct 2022, Publisher: Swedish Society for Anthropology and Geography, IF: 5.700, ISSN: 0044-0477.

«  Gupta S, Gupta YK. Combination of Zizyphus jujuba and silymarin showed better neuroprotective effect as compared to single agent in MCAo-induced focal cerebral ischemia in rats. J Ethnopharmacol. 2017;197:118-127. IF: 4.8, citation: 26: ISSN: 03788741

Gupta S, Sharma U, Jagannathan NR, Gupta YK. Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats. Exp Neurol. 2017; 288:25-37. IF; 4.6, citation: 44: ISSN: 00144886.

Dr. Shikha Saxena

Assistant Professor - III

Dr. Shikha Saxena has completed Phd from Amity University and Master's from Jamia Hamdard and joined Amity University in September 2010. She has 14 years of teaching experience. Her area of expertise is Analytical Chemistry, Bioinformatics, Cancer Research, Psoriasis and medicinal Chemistry. She believes in a multidisciplinary approach to research. She has actively worked in QAE panel. She has two patents granted to her credit. Dr Saxena has many research papers in impacted journals and has authored 3 books. She has many chapters in reputed books too. She is also a life member of IPGA and SPER.

 

RESEARCH INTERESTS

«  Bioinformatics

«  Pharmaceutical Validation and Analysis

Anti-Cancer

SELECTED PUBLICATIONS

 

Dr. Puneet Gupta

Assistant Professor - III

Dr. Puneet Gupta completed Ph.D. from Dr. A.P.J. Abdul Kalam Technical University and joined Amity Institute of Pharmacy on 15th May, 2015. He has 15 years of total experience in Teaching, Research & Industry. He has been awarded with a Research Grant of 31 Lakhs from Ministry of AYUSH, Govt. of India for the development of Novel formulation which will work as adjuvant to Anticancer Therapy. He has also been awarded with SRF Grant from ICMR for Antimicrobial Resistance Reversal, using phytomolecules. He published about a dozen papers, mostly in reputed Scopus and SCI indexed journals. He is working as Chief Coordinator of Drug Discovery & Development Cluster of Amity Universities, India in addition to his vibrant faculty position in Amity University Uttar Pradesh.

He has been very instrumental in motivating and supporting students to get Industrial Exposure. He is advisor and consultant to Pharmaceutical/IT Companies and dealt with numerous Clients from India and abroad. His collaborative skills have benefited many private and Govt organizations. He is a key person in signing MoUs between various Institutions and Industries. Serving mainly academia and research in his career, still his technical support to Pharmaceutical Industries is remarkable. He has vast knowledge of drug discovery/development, API synthesis, Manufacturing, Regulatory compliances, Marketing, supply chain Management etc in the arena of Pharmaceuticals. He organized huge number of National and International Conferences/Seminars/FDPs across India using his excellent organizational skills. He is a Central Executive Council member to Indian Hospital Pharmacists’ Association and Indian Pharmaceutical Association.

He signed MOU with Management and Science University, Malaysia in 2023 and going to sign MOU with University of Debrecen, Hungary in 2024. He has also delivered lectures at various National & International Conferences.

 

RESEARCH INTERESTS

  1. Herbal formulations for Psoriasis and Wound Healing
  2. Antimicrobial Resistance
  3. Cancer Research and Adjuvant herbal therapies for Cancer

 

SELECTED PUBLICATIONS

  • Sharma HK, Karna A, Verma SK, Gupta P, Nagpal D, Kumar A, et al. Exploring the Synergistic Effect of Thymol with Oxacillin against Methicillin Resistant Staphylococcus aureus. Indian journal of microbiology. 2024 May 23.
  • Singh N, Shaikh AM, Gupta P, Kovács B, Abuzinadah MF, Ahmad A, Goel R, Singh S, Vinayak C. Nanophytosomal Gel of Heydotis corymbosa (L.) Extract against Psoriasis: Characterisation, In Vitro and In Vivo Biological Activity. Pharmaceuticals. 2024; 17(2):213. DOI: https://doi.org/10.3390/ph17020213
  • Sharma HK, Gupta P, Nagpal D, Mukherjee M, Parmar VS, Lather V. Virtual screening and antimicrobial evaluation for identification of natural compounds as the prospective inhibitors of antibacterial drug resistance targets in Staphylococcus aureus. Fitoterapia. 2023; 168: 105554. DOI: https://doi.org/10.1016/j.fitote.2023.105554                 
  • Singh N, Gupta P, Goel R, Vinayak C, Sagar D, Gupta A. Accelerating healing of excisional wound with a hydrogel containing Hyacinth bean (Dolichos lablab) extract in a rat model. Current drug therapy. 2024; 19 (2): 239-249. DOI: https://doi.org/10.2174/1574885518666230526124031
  • Singh N, Yadav SD, Gupta P, Ali F, Arora S. Dermal Delivery of Hypericum perforatum (L.) Loaded Nanogel: Formulation to Preclinical Psoriasis Assessment. Recent Advances in Drug Delivery and Formulation [Internet]. 2024 May 17 [cited 2024 Jun 3]; e170524230069. Available from: https://pubmed.ncbi.nlm.nih.gov/38808393/
  • Pandey R, Gupta P. Reviewing the Therapeutic Potential of Plant-based Natural Products Against Multidrug-resistant Bacteria (MDR). Current Drug Research Reviews [Internet]. [cited 2024 Jun 3]; 16: 1–15. Available from: https://www.eurekaselect.com/article/139227
  • Gupta P, Singh N, Bharti C, Neha SL. Harnessing the potential of Litchi fruit Pericarp for wound mitigation in Wistar albino rats. Current Indian Sciences. 2023; 1: 1-10. DOI: 10.2174/2210299X01666230808152705
  • Gupta P, Singh N, Bharti C, Shanmugam SK. Evaluation of Hepatoprotective efficacy of a polyherbal Unani formulation Majoon-Najah against Cadmium chloride-induced liver damage. Current Drug Research Reviews. 2023; In press. DOI: 10.2174/2589977515666221207141645
  • Gupta P, Singh A, Singh N, Ali F, Tyagi A, Shanmugam SK. Healing Potential of Propolis Extract–Passiflora edulis Seed Oil Emulgel Against Excisional Wound: Biochemical, Histopathological, and Cytokines Level Evidence. ASSAY and Drug Development Technologies. 2022; 20(7): 300-316.

 

Dr. Smriti Sharma

Assistant Professor - II

Dr. Smriti Sharma completed PhD from Central Drug Research Institute, Lucknow, Dr. A.P.J. Abdul Kalam Technical University, Lucknow (AKTU) (formerly Uttar Pradesh Technical University, Lucknow). She joined Amity Institute of Pharmacy, Noida as an Assistant Professor. She has more than ten years of rich experience in research and teaching. Dr. Sharma has been awarded the prestigious CSIR-SRF-2009 for carrying out the research work. She also got the CDRI appreciation award for the paper published in Journal of Medicinal Chemistry (ACS Publications), 2011, 54(1), 302-311. She has extensive experience in carbohydrate based small molecule synthesis under mentorship of Dr. Arun Kumar Shaw (Rtd-Senior Principal Scientist & Professor AcSIR) from Central Drug Research Institute, Lucknow. She is one of the co-inventors of 2,3-Dideoxy Hex-2-enopyranosid-4-uloses and their derivatives as antitubercular agents and a process for preparation thereof (Indian Patent-281991).

Dr. Sharma has supervised PhD, M.Pharm and B.Pharm students for their research work, which has been published in quality journals with a good impact factor. She is the author of book chapters, more than 20 International research papers and review articles in peer reviewed journals. She has also served as a guest editor (Thematic issue: Pharmaceutical Science Strategies for Drug Therapeutic Advancement: Drug Discovery and Development) for Current Pharmaceutical Design (Bentham Sciences). She has also received the best scientific presentation award in International Conference on Emerging New World Order in the Post-pandemic Scenario held on 18-19th Feb 2022 at St. Xavier’s College, Jaipur, Rajasthan.

 

RESEARCH INTERESTS

«  Development of novel approaches for the synthesis and characterization of carbohydrates and heterocyclic derivatives to accelerate the discovery of drug leads.

«  Lead based design for the development of New chemical entities (NCE) of natural scaffolds against Parasitic and Microbial infections (tuberculosis, malaria, amoebiasis and leishmaniasis).

Computer Aided Drug Design, Artificial Intelligence and Machine Learning

SELECTED PUBLICATIONS

«  Juglone derivatives as antitubercular agents: A rationale for the activity profile. European Journal of Medicinal Chemistry, 2009, 44, 2847–2853. Smriti Sharma, Brij K. Sharma, Yenamandra S. Prabhakar. (Current IF 6.514)

«  Arylpiperazines for Management of Benign Prostatic Hyperplasia: Design, Synthesis, Quantitive Structure-Activity Relationships, and Pharmacokinetic Studies. Journal of Medicinal Chemistry, 2011, 54, 302–311. Amit Sarswat, Rajeev Kumar, Lalit Kumar, Nand Lal, Smriti Sharma, Yenamandra S. Prabhakar, Shailendra K. Pandey, Jawahar Lal, Vikas Verma, Ashish Jain, Jagdamba P. Maikhuri, Diwakar Dalela, Kirti, Gopal Gupta, and Vishnu L. Sharma. (Current IF 7.446)

«  Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents. European Journal of Medicinal Chemistry, 2014, 83, 474-489. Smriti Sharma, Mohammad Saquib, Saroj Verma, Nripendra N. Mishra, Praveen K. Shukla, Ranjana Srivastava, Yenamandra S. Prabhakar, Arun K. Shaw. (Current IF 6.514)

«  3D-QSAR studies on 2, 3-dideoxy hexenopyranosid-4-uloses as anti-tubercular agents targeting alpha-mannosidase. Bioorganic Chemistry, 2015, 59, 91-96. Priyanka Shah, Mohammad Saquib, Smriti Sharma, Irfan Husain, Sandeep Kumar Sharma, Vinayk Singh, Ranjana Srivastava, Arun K. Shaw, Mohammad Imran Siddiqi. (Current IF 5.275).

A Combined QSAR and Molecular Docking Approach for Identifying Pyrimidine Derivatives as Penicillin Binding Protein Inhibitors. Letters in Drug Design & Discovery, 2022, 19, 12, 1121-1135. Smriti Sharma, Brij K. Sharma, Surabhi Jain and Puja Gulyani. (Current IF 1.09).

Dr. Neha Jain

Assistant Professor - II

Dr. Neha Jain has a distinguished academic and research career in the field of Pharmaceutical Sciences. She completed her Ph.D. in Pharmaceutical Sciences from IFTM University, Moradabad, Uttar Pradesh. She holds an M.Pharm (Pharmaceutics) and a B.Pharm from Dr. A.P.J. Abdul Kalam Technical University (APJAKTU), formerly known as Uttar Pradesh Technical University (UPTU), Lucknow. In February 2016, Dr. Jain joined the Amity Institute of Pharmacy at Amity University, Noida, as a Teaching Associate. With 13 years of teaching and research experience, she has made significant contributions to her field. Her academic excellence has been recognized throughout her career, having received an academic excellence award consecutively for six years during her B.Pharm and M.Pharm studies. She also secured a silver medal in her B.Pharm. Dr. Jain has an impressive publication record with over 70 research and review papers published in Q1 and Q2 journals of Thomson Reuters, accumulating a total impact factor of 80. Additionally, she has authored one book, contributed to nine book chapters, and holds two granted patents. Her contributions to pharmaceutical sciences have been recognized with several prestigious awards, including the SPER-Women Forum Young Scientist Award in 2021, the SPER-Young Scientist Award in 2022, and the title of World Class Problem Solver, Inventor, and Pioneer by ReTHINK-India in 2024. Dr. Jain is a lifetime member of the Society of Pharmaceutical Education and Research (SPER) and has served as the National Joint Secretary in the SPER Women's Forum Council from 2020 to 2024. She has actively participated in and presented her research at various national and international conferences held in India.

 

RESEARCH INTERESTS

Design, development, and characterization of novel formulations for targeted drug delivery viz. Nanoparticles, Hydrogels, in situ gels, Films and patches.

SELECTED PUBLICATIONS

Parul Rohtagi, Unnati Garg, Neha Jain*, Manisha Pandey, Mohd Cairul Iqbal Mohd Amin, Bapi Gorain, Pradeep Kumar. Chitosan and hyaluronic acid-based nanocarriers for advanced cancer therapy and intervention. Biomaterials Advances 2023; 213733. (IF: 8).

Neha Jain, Upendra Nagaich, Manisha Pandey, Dinesh Kumar Chellappan, Kamal Dua. Genomic tools in disease stratification and personalized therapy advancements: A recent update on revolutionary tool in the treatment. EPMA Journal 2022; 1-20. (IF: 8.896)

Ritu Mishra, Neha Jain*, Shreya Kaul, Upendra Nagaich. Centre Composite Design-Based Optimization, Fabrication and Pharmacodynamic Assessment of Sulfasalazine Loaded Lipoidal Nanoparticles based Hydrogel for the Management of Rheumatoid Arthritis. Drug Delivery and Translational Research 2022. (IF: 5.671)

Neha Jain, Yuvika Singh, Aynaz Nouri, Unnati Garg, Manisha Pandey. Assessment of healing capacity of glucose-responsive smart gels on the diabetic wound: A comprehensive review. Journal of Drug Delivery Science and Technology 2024; 105403. (IF: 5)

Upendra Nagaich and Neha Gulati. Nanostructured Lipid Carriers (NLC) Based controlled release topical gel of Clobetasol Propionate: Design and In-vivo Characterization. Drug Delivery and Translational Research 2016; 6: 289-298. (IF: 3.395)

 

Dr. Hemlata Nimesh

Assistant Professor - II

Dr. Hemlata Nimesh working as an Assistant Professor in the Centre for Pharmaceutical Chemistry & Pharmaceutical Analysis, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh.  She worked as Associate professor in Lloyd School of Pharmacy, Greater Noida and as Guest lecture in Delhi Pharmaceutical Sciences & Research University (DPSRU), New Delhi. She also has industrial experience as Research Associate in Analytical R & D in Jubilant Chemsys Ltd Noida. She has completed her Ph.D. from Department of Chemistry, University of Delhi, M.S. Pharm. in Medicinal Chemistry from National Institute of Pharmaceutical Education and Research (NIPER-Mohali) and B. Pharm. from DIPSAR Delhi. She is the recipient of CSIR SRF and ICMR SRF. She had good publications with a high impact factor.

 

RESEARCH INTERESTS

«  Synthesis of heterocyclic compounds

«  Anticancer and Antibacterial activity evaluation

«  Pharmacokinetics and pharmacodynamics

Virtual screening of phytoconstituents

SELECTED PUBLICATIONS

«  Tandem Synthesis of Pyrroloacridones via [3 + 2] Alkyne Annulation/Ring-Opening with Concomitant Intramolecular Aldol Condensation. Akhilesh K. Verma, Siva K. Reddy Kotla, Trapti Aggarwal, Sonu Kumar, Hemlata Nimesh, and Rakesh K. Tiwari; J. Org. Chem., 2013, 78 (11), pp 5372–5384. (Impact Factor- 4.785)

«  Synthesis and Biological Evaluation of Novel Bisbenzimidazoles as Escherichia coli Topoisomerase IA Inhibitors and Potential Antibacterial Agents. Nimesh Hemlata, Sur Souvik, Sinha Devapriya, Yadav Pooja, Anand Prachi, Bajaj Priyanka, Virdi Jugsharan, and Tandon Vibha. J. Med. Chem., 2014, 57 (12), pp 5238–5257. (Impact Factor-  5.447)

«  Preclinical Evaluation of DMA, a Bisbenzimidazole, as Radioprotector: Toxicity, Pharmacokinetics, and Biodistribution Studies in Balb/c Mice. Nimesh H, Tiwari V, Yang C, Gundala SR, Chuttani K, Hazari PP, Mishra AK, Sharma A, Lal J, Katyal A, Aneja R, Tandon V. Mol Pharmacol. 2015 Oct; 88(4):768-78. doi: 10.1124/mol.115.098376. Epub 2015 Aug 3. (Impact Factor-  4.128)

«  Akt1/NFκB signaling pathway activation by a small molecule DMA confers radioprotection to intestinal epithelium in xenograft model. Vinod Tiwari, Mohammad Zahid Kamran, Atul Ranjan, Hemlata Nimesh, Manish Singh, Vibha Tandon. Free Radical Biology and Medicine 108 (2017) 564–574. (Impact Factor-  5.736)

Meenakshi Gupta, Hemlata Nimesh, Anwar L Bilgrami, Maryam Sarwat. A Saffron based Polyherbal Formulation DuK Prevents Hepatocellular Carcinoma in Male Wistar Rats. Current Cancer Drug Targets. 2023 Aug 18. doi: 10.2174/1568009623666230818115905

Dr. Indu Singh

Assistant Professor - II

Dr. Indu Singh is presently working as Assistant Professor in Centre of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh. She has also worked as Assistant Professor, in Department of Pharmaceutical Sciences, Babasaheb Bhimrao Ambedkar Central University, Lucknow. She has 08 years’ post-PhD teaching experience. She possesses Bachelor of Pharmacy degree (B. Pharm.), master’s degree (M. Pharm) and doctorate degree (PhD) in Pharmaceutics. She has done her PhD in the area of Nanomedicines (Bioconjugated nanotherapeutics for tumor targeting) from National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, GOI.  She has been a Gold medalist in M. Pharm and B. Pharm. She was awarded with Sumitra Devi Wahi Memorial Award for best outgoing B. Pharm final year student of the year in 2008. She has been a recipient of Graduate Aptitude test in Engineering (GATE) scholarship by Ministry of Human Resource Development (MHRD) and Fellowship from Ministry of Chemicals and Fertilizers, GOI for persuing M. Pharm and PhD respectively. She is a registered pharmacist with Pharmacy Council of India; Uttar Pradesh Pharmacy Council, Lucknow. She Qualified Women Scientist-C (WOS-C) examinations (KIRAN-IPR) conducted by Department of Science and Technology (DST), New Delhi, India in 2015. She was also awarded with Young Scientist International Travel Grant from Council of Scientific and Industrial Research (CSIR), India to attend 6th International Conference on Nanomaterials - Research & Application, NANOCON-2014 at Brno, Czech Republic, EU. She has several awards to her credit for oral and poster presentation in various national and international conferences. She has published more than 30 research papers in international journals of repute with good impact factor and is author of 10 book chapters and 4 books. She has also filed 3 patents.

RESEARCH INTERESTS

«  Conjugated/Bioconjugated nanoparticles and dendrimers for Brain/Breast cancer Targeting

Novel Drug delivery Systems for Skin diseases/Epilepsy/Schizophrenia

SELECTED PUBLICATIONS

«  Singh I, Swami R, Khan W, Sistla R. Lymphatic system: a prospective area for advanced targeting of particulate drug carriers. Expert Opinion on Drug Delivery. 2014, Feb; 11(2):211-29. (I.F 8.19)

«  Singh I, Swami R, Pooja D, Jeenger M, Khan W, Sistla R. Lactoferrin conjugated solid lipid nanoparticle: A ligand mediated delivery of docetaxel to brain, Journal of drug targeting. 2016 July; 1-12. (I.F 5.016)

«  Singh I, Swami R, Jeenger M, Khan W, Sistla R. P- aminophenyl-α-D-Mannopyranoside grafter solid lipid nanoparticle for targeted delivery of docetaxel to brain, Chemistry and Physics of Lipids. 2015 March; 188: 1-9. (I.F 3.57)

«  Swami R, Singh I, Jeenger M, Naidu VGM, Khan W, Sistla R. Adenosine modified lipidic nanoparticles for enhanced tumor targeting, International Journal of Pharmaceutics. 2015 May 30; 486(1-2):287-96. (I.F 6.51)

Swami R, Singh I, Khan W, Sistla R. Diseases originate and terminate by genes: Unraveling non-viral gene delivery. Drug Delivery and Translational Research. 2013 Dec; 3(6): 593-610. (I.F 5.67)

Dr. Navneet Sharma

Assistant Professor - II

Dr Navneet Sharma completed his PhD from University of Delhi at Institute of Nuclear Medicine and Allied Sciences (INMAS) Defense Research and Development Organization (DRDO) and later completed his postdoctoral work at Indian Institute of Technology Delhi. His work was inclined more towards applied R&D especial needs-based product development. He had developed a novel technique for the radiological decontamination of the skin using novel complexing agents. The technology was licensed to the industry. He had devised and applied pharmacoscintigraphic procedures for its preclinical evaluation of the drug delivery systems in various experimental models of disease. In collaboration with INMAS-DRDO, he developed dermal formulations for the broad-spectrum decontamination and healing of radiation-induced wounds. Both the formulations were licensed to the industry.

His research work is exclusively focused on Prehospital casualty care, exclusively focused on hemostasis and medical management of the Chemical, Biological, Radiological and Nuclear (CBRN) Emergencies. Currently, He is working on the universal formulation for the CBRN decontamination of skin. The first quarter of 2020 motivated him to direct his focus towards developing solutions for viral decontamination from living and inanimate surfaces. He was among the 4 Eminent Scientist from the country who got the fast track Covid-19 decontamination project from Department of Sciences and Technology (DST). He had acclaimed several national and international awards from Govt of India and associate nation's   most prominent among them are the Shanghai Cooperation Organization (SCO) and Ministry of External Affairs, Government of India-DST Covid-19 best innovation award 2020 and Department of Science and Technology, Young Scientist Award-2018 and Young Scientist Award-2022. He has acclaimed several prestigious fellowships including Indian National Science Academy (INSA), DRDO, CSIR SRA & RA. Currently he is an investigator in several projects from DST, National Textile Technology Mission (NTTM) and DRDO. Filled and granted more than 10 patents, 4 technologies successfully transferred to the industry. He had more than 50 publications including several book chapters, authored, and edited eight books for Elsevier, DGLSDRDO, etc.

RESEARCH INTERESTS

«  Soft materials

«  Radiopharmaceuticals

CBRN Casualty management 

SELECTED PUBLICATIONS

  • Ashrit Nair, Aditya Dahiya, Pooja Yadav, Bhupendra Singh Butola, Navneet Sharma* Materials for the management of traumatic Wounds: A descriptive review, 112475 ,31 October 2024. The European Polymer Journal https://doi.org/10.1016/j.eurpolymj.2023.112475
  • Ashrit Nair, Pooja Yadav, Amanpreet Behl, Shweta Kulshrestha, Bhupendra Singh Butola, Navneet Sharma*, Toxic Blister agents: Chemistry, mode of their action and effective treatment strategies, Chemico-Biological Interactions, 350 (2021); 109654.. ISSN: 0009-2797, DOI: 10.1016/j.cbi.2021.109654
  •  Navneet Sharma, Mamta Chaudhary, Bhupendra Singh Butola, Joseph Kingston Jeyabalaji, Dharm Pal Pathak, Rakesh Kumar Sharma. Preparation, characterization, and evaluation of the Zinc titanate and Silver nitrate incorporated wipes for topical chemical and biological decontamination, Material Science & Engineering: C, 96(2019); 183-196. .ISSN: 0928- 4931, DOI: 10.1016/j.msec.2018.10.056
  • Navneet Sharma, Himanshu Ojha, Dharam Pal Pathak, Rajeev Goel, and Rakesh Kumar Sharma. Ex-vivo complexation, skin permeation, interaction and cytodermal toxicity studies of p- tertbutylcalix[4]arene nanoemulsion for radiation decontamination. Life Sciences, 168 (2017); 65–76. ISSN: 0024-3205, DOI: 10.1016/j.lfs.2016.11.007 7.
  • Navneet Sharma, Rita Kakkar, Prerna Bansal, Anju Singh, Himanshu Ojha, Dharam Pal Pathak, and Rakesh Kumar Sharma. Host–guest complexation studies of ptertbutylcalix[4]arene against ions of interest for radiological decontamination, Inorganica Chimica Acta, 484 (2019); 111–124. .ISSN: 0020-1693 DOI: 10.1016/j.ica.2018.09.007

 

Dr. Kavita Munjal

Assistant Professor - II

Dr. Kavita Munjal is presently working as Assistant Professor in Centre of Pharmacognosy, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh. She has also worked as Assistant Professor, in MM college of Pharmacy, Markandeshwar University, Ambala and B S Anangpuria Institute of Pharmacy, Faridabad. She has total 6 years teaching experience. She possesses Bachelor of Pharmacy degree (B. Pharm.), master’s degree (M. Pharm in Pharmacognosy) and doctorate degree (PhD) in Pharmacognosy & Phytochemistry. She qualified the highly competitive graduate pharmacy aptitude test (GPAT), and enrolled in Indo Soviet Friendship (ISF) college of Pharmacy, a premier institute of pharma education in India, to pursue my Masters studies in Pharmacognosy program (Specialization – Plant sciences). Her Masters in Pharmacy (M. Pharm) project was completed under the guidance of Dr. Jai Malik at Indo Soviet Friendship (ISF) college of Pharmacy, Punjab, India and was aimed at the exploration of the “Evaluation of Cinnamomum zeylanicum (Bark) against STZ induced experimental dementia of Alzheimer’s type”. Further, she enrolled in the doctoral studies program in Pharmacognosy and Phytochemistry (2015) at the School of Pharmaceutical Education & Research (SPER), Jamia Hamdard University, New Delhi, India and submitted my Ph.D. degree (2020) in Pharmacognosy and Phytochemistry. Her doctoral studies work, entitled: “Preparative isolation and characterization of polyphenols from Alpinia galanga Linn., Garcinia indica Choisy. and Glycyrrhiza glabra Linn., and their role as anti-obesity therapeutics” was carried out under the supervision of Dr. Showkat Rasool Mir. She is a registered pharmacist with Pharmacy Council of India; Haryana State Pharmacy Council, Haryana. She has also qualified UGC NET examination. She is also Technical committee member at Department of AYUSH, Bureau of Indian Standards.She has several awards to her credit for oral and poster presentation in various national and international conferences. She has published more than 30 research papers in international journals of repute like The Lancet with good impact factor and is author of 10 book chapters and 3 books. She has also filed 4 patents.

 

RESEARCH INTERESTS

«  Study of phytomedicines and their role in healthcare

«  Pharmacological screening and bioavailability enhancement aspect of natural products

«  Isolation and quantification of secondary metabolites of some important medicinal plants with special emphasis on bioactive constituents, using various chromatographic (TLC, HPTLC) techniques

Identification and characterization of natural products by modern analytical tools like IR, UV, NMR and Mass spectroscop

SELECTED PUBLICATIONS

«  Vollset, Stein Emil, Ababneh, Hazim S., Abate, Yohannes Habtegiorgis, Kavita Munjal et al., 2024. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021. The Lancet. 403, 2204-2256. https://doi.org/10.1016/S0140-6736(24)00685-8. IF = 168.9

«  George A. Mensah, Valentin Fuster, Christopher J.L. Murray, Gregory A. Roth, Kavita Munjal et al., 2023. Global burden of cardiovascular diseases and risks, 1990-2022. Journal of the American college of cardiology. 82 (25) 2350–2473.https://doi.org/10.1016/j.jacc.2023.11.007 IF – 24

«  Munjal, K., Ahmad, S., Gupta, A., Haye, A., Amin, S., Mir, S.R., 2020. Polyphenol-enriched fraction and the compounds isolated from Garcinia indica fruits ameliorate obesity through suppression of digestive enzymes and oxidative stress. Pharmacognosy Magazine. 16(70), S236- S245.

«  Malik, J., Munjal, K., Deshmukh, R. 2015. Attenuating effect of standardized lyophilized Cinnamomum zeylanicum bark extract against streptozotocin- induced experimental dementia of Alzheimer’s type. Journal of Basic and Clinical Physiology and Pharmacology. 26(3), 275-285.

Chopra, H., Annu, Shin, DK., Munjal, K., Priyanka, Dhama, K., Emran., TB. Revolutionizing Clinical Trials: The role of AI in accelerating Medical breakthroughouts. International Journal of Surgery. 109(12): 4211–4220. https://doi.org/10.1097%2FJS9.0000000000000705. IF – 15.3

Dr. Priyanka Saroj

Assistant Professor - II

Dr. Priyanka Saroj currently serves as an Assistant Professor at Amity College of Pharmacy, Amity University, Noida. She holds Ph.D. in Pharmacology from Panjab University, Chandigarh, and M.Pharm from TMU University. Dr. Priyanka boasts an outstanding research background, making notable contributions to the field of neuroscience. She has garnered international recognition, receiving prestigious grants such as the IBRO-International Travel Grant to attend the British Neuroscience Association (BNA) conference in Ireland, and the IBRO-short stay award for an internship at the Florey Institute of Neuroscience and Mental Health in Australia. She has also presented her research at the Australian Neuroscience Society (ANS) in Australia and received the IBRO-SfN Travel Grant to present her work at the Annual Meeting of the Society for Neuroscience in California.

With over 7 years of teaching and research expertise, Dr. Priyanka's scholarly contributions are evident through her numerous publications in peer-reviewed international journals and her involvement in various book chapters. Furthermore, Dr. Priyanka's involvement in research projects related to other neurological disorders such as Parkinson’s disease, Alzheimer's disease, and Depression demonstrates her broad expertise and commitment to addressing diverse challenges in neuroscience. By actively participating in these projects, she has contributed to the collective efforts aimed at unravelling the complexities of these disorders and developing effective interventions to improve patient outcomes.

RESEARCH INTERESTS

  • Pharmacology
  • Neuroscience
  • Neurodegenerative
  • Neuroinflammation
  • Toxicology

 

SELECTED PUBLICATIONS

1. Priyanka Saroj, Priya Badyal, Anurag Kuhad (2022) “Animals models of Huntington’s disease” Bentham Science Publishers, (26)182-207

 

2. Priyanka Saroj, Yashika Bansal, Raghunath Singh, Ansab Akhtar, Rupinder Kaur Sodhi, Mahendra Bishnoi, Sangeeta Pilkhwal Sah, Anurag Kuhad (2021) “Neuroprotective efects of Rofumilast against Quinolinic acid-induced rat model of Huntington’s disease through inhibition of NF-κB mediated neuroinfammatory markers and activation of cAMP/CREB/ BDNF signaling pathway” Inflammopharmacology, 29, 499-511

 

3. Rupinder Kaur Sodhi, Yashika Bansal, Raghunath Singh, Priyanka Saroj, Ranjana Bhandari, Baldeep Kumar, Anurag Kuhad (2021) “IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson's

disease” Neurotoxicology 84,184-197

 

4. Angel Joshi, Ansab Akhtar, Priyanka Saroj, Anurag Kuhad, Sangeeta Pilkhwal Sah (2022) “Antidepressant-like effect of sodium orthovanadate in a mouse model of chronic unpredictable mild stress” European Journal of Pharmacology 919

 

5. Ansab Akhtar, Jatinder Dhaliwal, Priyanka Saroj Ankit Uniyal, Mahendra Bishnoi, Sangeeta Pilkhwal Sah, (2020) “ Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alheimer’s like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK- 3B pathway” Inflammopharmacology, 28,385-400

Dr. Mahendra Yadav

Assistant Professor - II

Dr. Mahendra Yadav completed his Ph.D. from Delhi Pharmaceutical Sciences and Research University in 2022. With approximately 10 years of teaching and research experience in Pharmacology and Toxicology, Dr. Yadav has conducted various preclinical studies focusing on urolithiasis, inflammation, arthritis, internal decorporation of radionuclides, and toxicity studies.

Currently, Dr. Yadav serves as an Assistant Professor of Pharmacology at the Amity Institute of Pharmacy, Amity University, Noida, UP. He previously worked as a Senior Research Fellow at the Institute of Nuclear Medicine and Allied Science (INMAS), Defence Research and Development Organization (DRDO), New Delhi. There, he contributed to a project on the internal decorporation of radionuclides from the body, aimed at preparing for potential future nuclear accident scenarios. Additionally, he served as a Senior Research Fellow (Pharmacology) at the Regional Ayurveda Research Institute for Drug Development, Gwalior, MP, under the Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi. His work there included the toxicological and antiarthritic evaluation of Laghu Vishagarbha Taila.

Dr. Yadav has over 16 publications in national and international journals. He was awarded the DRDO Junior Research Fellowship in 2017 and qualified for the Graduate Pharmacy Aptitude Test (GPAT) in 2011.

 

RESEARCH INTERESTS

«  Pharmacology and Toxicology

Internal Decorporation of Radionuclides

SELECTED PUBLICATIONS

«  Mahendra Yadav, Vivek Kumar, Nidhi Sandal, Meenakshi Kanwar Chauhan. Quantitative evaluation of Mercury Adsorption and Removal Efficacy of Spirulina (Arthrospira platensis) Powder in Mice. Archives of Microbiology 204, 387 (2022). IF 2.667

«  Mahendra Yadav, Komal Rani, Nidhi Sandal, Meenakshi Kanwar Chauhan. An approach towards safe and sustainable use of green alga Chlorella for removal of radionuclides and heavy metal ions. Journal of Applied Phycology, 34, 2117-2133 (2022). IF 3.404

«  Mahendra Yadav, Vivek Kumar, Nidhi Sandal, Meenakshi Kanwar Chauhan. Quantitative evaluation of Chlorella vulgaris for removal of toxic metals from body. Journal of Applied Phycology 34, 2743-2754 (2022). Doi:10.1007/s10811-021-02640-8 IF 3.404

«  Mahendra Yadav, Pooja Sharma, Himanshu Kushwah, Meenakshi K Chauhan, Nidhi Sandal. Assessment of toxicological profile of Chlorella (C. vulgaris) powder by performing acute and sub-acute toxicity study. Journal of Applied Phycology 34, 363–373 (2022). Doi: 10.1007/s10811-021-02632-8. IF 3.404

Mahendra Yadav, Ravi Soni, Meenakshi Kanwar Chauhan, Nidhi Sandal. Cellular and physiological approaches to evaluate the chelating effect of Chlorella on metal ion stressed lymphocytes. Biometals 34, 351–363 (2021). IF 3.378

Dr. Shreya Kaul

Assistant Professor - I

Dr. Shreya Kaul has a robust academic and research background with significant contributions to the field of pharmaceutics.  She earned her Ph.D. in Pharmaceutical Sciences from IFTM University, Moradabad, India, in 2022, following her M.Pharm in Pharmaceutics and B.Pharm from Amity University Noida. And holds a Post Graduate Diploma in Drug Regulatory Affairs from Jamia Hamdard, Delhi. Dr. Shreya is an Assistant Professor at Amity University Noida, holding this position since April 2022. She previously served as an Editorial Assistant at the Journal of Advanced Pharmaceutical Technology & Research, (a Thomson Reuters, PubMed, and SCOPUS indexed journal with an impact factor). Dr. Kaul's research primarily focuses on targeted drug delivery systems, nanotechnology, ocular drug delivery and topical disease management. She has an extensive publication record in prestigious journals, with research and review articles published in high impact journals (Q1 and Q2 Thomson Reuters), achieving a combined impact factor of more than 60. Additionally, she has contributed to several book chapters, and holds one granted patent. Dr. Shreya serves as a reviewer for several prestigious journals published by renowned international publishers such as Taylor and Francis, Elsevier, Springer, MDPI, Wolters Kluwer and Bentham. She has received numerous awards for her research and presentations. She was recognized with an Innovative Researcher Award at Vivekananda Global University, Jaipur in 2022 and received the Women Forum-Best Student Award at Ganpat University, Mehsana in 2021. She was also awarded the Best Student Award (PG) during Society of Pharmaceutical Education and Research (SPER) international conference at B.S. Abdur Rehman Crescent Institute of Science & Technology, Chennai in 2018. Additionally, Dr. Shreya has been honored for her oral and poster presentations at various national and international conferences. Dr. Shreya is a lifetime member of the SPER and is currently serving as the National Joint Secretary of the SPER Women's Forum Council, a position she has held since 2020.

 

RESEARCH INTERESTS

«  Novel drug delivery Systems

«  Nanoparticles

«  Ocular delivery

Topical drug delivery

SELECTED PUBLICATIONS

«  Shreya Kaul, Upendra Nagaich, Navneet Verma. Preclinical Assessment of Nanostructured Liquid Crystalline Particles for the Management of Bacterial Keratitis: In Vivo And Pharmacokinetics Study. Drug Delivery and Translation Research. 2022; 12(7): 1719-1737. (IF-5.7).

 

«  Shreya Kaul, Neha Jain, Upendra Nagaich. Ultra-Deformable Vesicles for Boosting Transdermal Delivery of 2-Arylpropionic Acid Class Drug for Management of Musculoskeletal Pain. Journal of Pharmaceutical Investigation. 2022; 52: 217-231. (IF-5.5).

 

«  Ritu Mishra, Neha Jain, Shreya Kaul, Upendra Nagaich. Centre Composite Design-Based Optimization, Fabrication and Pharmacodynamic Assessment of Sulfasalazine Loaded Lipoidal Nanoparticles based Hydrogel for the Management of Rheumatoid Arthritis. Drug Delivery and Translational Research 2022. (IF: 5.67)

 

«  Megha Garg, Neha Jain, Shreya Kaul, Vineet Kumar Rai, Upendra Nagaich. Recent advancements in the expedition of microneedles: from lab worktops to diagnostic care centers. Microchimica Acta. 2023; 190(8):301. (IF-6.32)

 

Aarushi Kaith, Neha Jain, Shreya Kaul*, Upendra Nagaich. Polysaccharide-infused bio-fabrication: Advancements in 3D bioprinting for tissue engineering and bone regeneration. Materials Today Communication. 2023; 40: 109429. (IF-3.9).

Dr. Saurabh Mittal

Assistant Professor - II

Dr. Saurabh Mittal is currently working as an Assistant Professor in the Department of Pharmaceutics at the Amity Institute of Pharmacy, Amity University, Noida Campus. He completed his Ph.D. and M. Pharm in Pharmaceutics from Jamia Hamdard, Delhi, and his B. Pharm from DIPSAR, Delhi, with distinction. He qualified GPAT exam with a very good percentile. Dr. Mittal has one year of experience as a Market Research Analyst at The Smart Cube, Noida, where he worked on various projects related to the pharmaceutical field for major clients such as J&J, Roche, GSK, and many others.

He has various publications in international journals, being the first author in most of them. He worked as a Senior Research Fellow (ICMR) at Jamia Hamdard, Delhi, under the guidance of Prof. (Dr.) Sanjula Baboota. He has research experience in the fields of analytical method development, Quality by Design, and the development and characterization of various nano-formulations (NLC, Nanoemulsion), along with cell line studies and animal studies, particularly for dermal, neurological, and cancer diseases. His work based on these approaches has been highly cited in recent years, with a total of over 200 citations, an h-index of 6, and an i10-index of 5 as of June 2024, according to Google Scholar.

 

RESEARCH INTERESTS

«  Formulation Development and Optimization via Quality by Design Approach and Design of Experiment

«  Bioavailability enhancement using lipid-based drug delivery.

«  Intranasal delivery of therapeutic agents for bioavailability enhancement and delivery for brain related diseases.

Lipid based drug delivery systems for prevention and treatment of cancer

SELECTED PUBLICATIONS

  • Reena, Km, Saurabh Mittal, Mohammad Faizan, Iram Jahan, Yasir Rahman, Rahmuddin Khan, Lalit Singh, Abdulsalam Alhalmi, Omar M. Noman, and Ahmad Alahdab. "Enhancement of Curcumin’s Anti-Psoriatic Efficacy via Formulation into Tea Tree Oil-Based Emulgel." Gels, 2023;9(12):973. ISSN: 2310-2861 Impact Factor:  4.6.
  • Saurabh Mittal, Sadia Shah, Harlokesh Narayan Yadav, Javed Ali, Madan Mohan Gupta, Sanjula Baboota. “Quality by design engineered, enhanced anticancer activity of temozolomide and resveratrol coloaded NLC and brain targeting via lactoferrin conjugation in treatment of glioblastoma”. European Journal of Pharmaceutics and Biopharmaceutics. 2023;191:175-88. ISSN: 0939-6411. Impact Factor:  4.9.
  • Nupur Shrivastava, Ankit Parikh, Rikeshwer Dewangan, Largee Biswas, Anita Kamra Verma, Saurabh Mittal, Javed Ali, Sanjay Garg, Sanjula Baboota. “Optimized solid self- nanoemulsifying system: A potential nanoplatform for enhancing anti tumor activity of combination of tamoxifen and resveratrol for treatment of breast cancer” Pharmaceutics. ISSN: 1999-4923. Impact Factor:  6.525.
  • Saurabh Mittal, Javed Ali, Sanjula Baboota (2021) Enhanced anti-psoriatic activity of tacrolimus loaded nanoemulsion gel via omega 3 - fatty acid (EPA and DHA) rich oils- fish oil and linseed oil. Journal of Drug Delivery Science and Technology. 63: 102458. ISSN: 1773-2247. Impact Factor: 5.062. https://doi.org/10.1016/j.jddst.2021.102458.

 

Dr. Sweta Bawari

Assistant Professor - I

Dr. Sweta Bawari is a distinguished researcher with a deep-seated interest in pharmacology and toxicology, focusing primarily on the exploration of phytotherapeutics, emphasizing the pharmacological potential of natural products and their applications in various medical fields, including pain management, cancer therapy, neuroprotection, and renal health. She has made significant contributions to her field, as evidenced by her receipt of the prestigious INSPIRE fellowship from the Department of Science and Technology (Innovation in Science Pursuit for Inspired Research (INSPIRE) program), Government of India.

Dr. Bawari holds a Ph.D. in Pharmacology from the Department of Pharmaceutical Sciences, Kumaun University, Nainital, where she worked on evaluating the role of phytotherapeutics in mitigating urolithiasis. Her research journey began with an M. Pharm project on Reproductive Toxicity Evaluation studies at the Indian Institute of Integrative Medicine (IIIM), CSIR, Jammu. Dr. Bawari excelled in her academic endeavours, securing the first rank at the university level in her Master of Pharmacy (Pharmacology) program.

Dr. Bawari's scholarly output includes numerous publications in high-impact journals such as Pharmacology & Therapeutics, Neuroscience & Biobehavioral Reviews, Pharmacological Research, and Current Neuropharmacology. Her works have received acclaim for their depth and scientific rigor. Dr. Bawari has also contributed to the intellectual property landscape with two published patents. In addition to her publications and patents, Dr. Bawari has authored several book chapters and presented her findings at numerous national and international conferences. Her contributions extend to organizing and participating in significant workshops and conferences, enhancing the dissemination and application of her research.

Currently, Dr. Bawari serves as an Assistant Professor at the Amity Institute of Pharmacy, Amity University, Noida. Her previous academic positions include roles at Noida Institute of Engineering and Technology and Sharda University. She is an active life member of several professional organizations, including the International Natural Product Sciences Taskforce and the Association of Pharmaceutical Teachers of India.

Dr. Bawari's career is marked by a commitment to advancing the field of pharmacology through innovative research, comprehensive teaching, and active participation in the scientific community.

RESEARCH INTERESTS

·         Ethnopharmacology and Traditional Medicine

·         Renal Health and Nephrolithiasis

·         Pain Management

·         Cancer Research

Neuropharmacology

SELECTED PUBLICATIONS

  1. Himalayan Citrus jambhiri juice reduced renal crystallization in nephrolithiasis by possible inhibition of glycolate oxidase and matrix metalloproteinases. Journal of Ethnopharmacology, 2023, 306. Impact factor 5.4
  2. Metabolomics-based pharmaceutical evaluation of different parts of Swertia chirayita (Roxb.) Buch.-Ham. ex C.B. Clarke from the western Himalayas. Journal of Separation Science, 2024, 47(1), 2300795. Impact factor 3.1
  3. Himalayan Pyracantha crenulata (D. Don ) M. Roem. leaf and fruit extracts alleviate algesia through COX - 2 and Mu-opioid receptor mediated pathways. Journal of Ethnopharmacology, 2024, 318, 117004. Impact factor 5.4
  4. Targeting the crosstalk between canonical Wnt/β-catenin and inflammatory signaling cascades: A novel strategy for cancer prevention and therapy. Pharmacology & Therapeutics, 2021, 227; 107876.  Impact factor 13.5
  5. Targeting BDNF signaling by natural products: novel synaptic repair therapeutics for neurodegeneration and behavior disorders. Pharmacological Research, 2019, 148, 104458. Impact factor 9.3

 

 

Dr. Saurabh Verma

Assistant Professor - I

Dr. Saurabh Verma is currently an Assistant Professor at the Amity Institute of Pharmacy, Amity University, Noida, U.P. He earned his B. Pharm degree from AKTU in 2014 and his M.S. Pharm degree from NIPER-Kolkata in 2016. In 2023, Dr. Verma completed his Ph.D. at CSIR-CDRI, Lucknow, and was awarded a Ph.D. in Pharmaceutical Science by AcSIR, Ghaziabad.

Dr. Verma has received prestigious national fellowships, including GPAT, NIPER, and CSIR-NET-JRF, and Postdoctoral Fellow at NIB. His research experience includes roles as a junior and senior research fellow at CSIR-CDRI, Lucknow.

He possesses extensive expertise in the analytical and bioanalytical method development and validation of phytochemical, synthetic, and peptide compounds using HPLC and LC-MS/MS. His research skills encompass the design, execution, analysis, and interpretation of pharmacokinetic and pharmacodynamic studies. Dr. Verma is also proficient in in-vitro, in-situ, and in-vivo preclinical pharmacokinetic and drug metabolism studies, as well as molecular biology techniques such as RNA/DNA isolation, cDNA preparation, protein/ribosome purification, and operating RT-PCR and western blotting.

Dr. Verma has a strong publication record, with papers in reputable international journals such as the International Journal of Chromatography, European Journal of Pharmacology, Life Sciences, Frontiers in Endocrinology, Peptides, Journal of Biochemical and Molecular Toxicology, Cytokines, Nanomedicines, Bioanalysis, and International Journal of Pharmaceutics. He has published 22 papers in Scopus/SCI indexed journals within a five-year period (2018-2023), achieving a cumulative impact factor of around 100. His research interest score is 120, with 148 citations and an h-index of 6.

 

RESEARCH INTERESTS

  • Pharmacokinetic/Toxicokinetic studies: In-vivo/in vitro Pharmacodynamic/ pharmacokinetics/toxicokinetic (bioavailability, excretion, tissue distribution and dose proportionality studies) of xenobiotics in preclinical animals using different route of administration (Oral, I.V., I.P., I.M. etc.).
  • Bio-analysis: Method development and validation for xenobiotics quantification in different matrices (e.g. blood, plasma, urine, tissues, water and food commodities etc.) using UPLC, LC-MS/MS and GC-MS/MS.
  • In-vitro metabolism: Metabolic stability, metabolite identification, CYP450/UGTs phenoytping & inhibition studies of xenobiotics using recombinant enzymes/microsomes/S9 fraction/hepatocytes as test system.
  • Interaction studies: Drug-drug and food-drug interaction studies using in-vitro test systems and in-vivo prediction using mathematical models.

 

SELECTED PUBLICATIONS

Gupta, Sarika, Nitin Sharma, Sandeep Arora, and Saurabh Verma. "Diabetes: a review of its pathophysiology, and advanced methods of mitigation." Current Medical Research and Opinion just-accepted (2024): 1-24.

Husain, Athar, Mohammad Irshad Reza, Shailesh Dadge, Anees A. Syed, Pragati Singh, Saurabh Verma, Roshan Katekar, Ashish Kumar, and Jiaur R. Gayen. "Preclinical pharmacokinetics and herb-drug interaction studies of atorvastatin co-administered with the herbal slimming products." Indian Journal of Traditional Knowledge (IJTK) 22, no. 4 (2023): 727-738.

Garg R, Agarwal A, Katekar R, Goand UK, Singh N, Yadav S, Rathaur S, Verma S, Maity D, Vishwakarma S, Gayen JR. Pancreastatin inhibitor PSTi8 ameliorates insulin resistance by decreasing fat accumulation and oxidative stress in high -fat diet -fed mice. Amino Acids. 2023 Nov;55(11):1587 –600.

Goand, Umesh K., Saurabh Verma, Inklisan Patel, Saima Tasneem, Richa Garg, and Jiaur R. Gayen. "Immuno - metabolic effect of pancreastatin inhibitor PSTi8 in diet induced obese mice: In vitro and in vivo findings." Life Science s 316 (2023): 121415 .

Garg, Richa, Roshan Katekar, Shahid Parwez, Arun Agarwal, Sudhanshu Sahu, Shailesh Dadge, Saurabh Verma, Umesh K. Goand, Mohammad Imran Siddiqi, and Jiaur R. Gayen. "Pancreastatin inhibitor PSTi8 ameliorates streptozotocin -induced diabetes by suppressing hepatic glucose production." European Journal of Pharmacology 944 (2023): 175559 .

Yadav, Pavan K., Ravi Saklani, Amrendra K. Tiwari, Saurabh Verma, Rafquat Rana, Divya Chauhan, Pooja Yadav et al. "Enhanced apoptosis and mitochondrial cell death by paclitaxel - loaded TPP -TPGS1000 –functionalized nanoemulsion." Nanomedicin e 18, no. 4 (2023): 343 -366 .

Dadge, Shailesh D., Neerja Tiwari, Athar Husain, Saurabh Verma, Arun Agarwal, Richa Garg, Srikanta K. Rath, Karuna Shanker, and Jiaur R. Gayen. "Simultaneous estimation of five biomarkers of neuroprotective herb Ashwagandha NMITLI -118R AF1 in rat plasma and brain using LC -ESI -MS/MS: application to its pharmacokinetic and stability studies." Journal of Chromatography B 1228 (2023): 123834 .

Yadav, Pavan K., Ravi Saklani, Amrendra K. Tiwari, Saurabh Verma, Divya Chauhan, Pooja Yadav, Rafquat Rana et al. "Ratiometric codelivery of Paclitaxel and Baicalein loaded nanoemulsion for enhancement of breast cancer treatment." International Journal of Pharmaceutic s 643 (2023): 123209 .

Verma, Saurabh, Umesh K. Goand, Shivam Rathaur, Richa Garg, Roshan Katekar, and Jiaur R. Gayen. "The combined effect of Raspberry Ketone with Resveratrol against oxidative stress and steatohepatitis in rats: Pharmacokinetic and pharmacodynamic studies." Journal of Biochemical and Molecular Toxicology 37, no. 6 (2023): e23336 .

Verma, Saurabh, Umesh K. Goand, Richa Garg, Athar Husain, Roshan A. Katekar, Mohammed Riyazuddin, Shailesh Dadge, and Jiaur R. Gayen. "LC –MS/MS method for quantification of raspberry ketone in rat plasma: application to preclinical pharmacokinetic studies." Bioanalysi s 15, no. 2 (2023): 83 -98 .

Katekar, Roshan, Pragati Singh, Richa Garg, Saurabh Verma, and Jiaur R. Gayen. "Emerging nanotechnology based combination therapies of taxanes for multiple drug-resistant cancers." Pharmaceutical Development and Technology 27, no. 1 (2022): 95- 107.

Kulkarni, Chirag, Shivani Sharma, Prateek Bora, Saurabh Verma, Swati Rajput, Konica Porwal, Srikanta Kumar Rath, Jiaur R. Gayen, Upendra Sharma, and Naibedya Chattopadhyay. "A novel extraction method enhanced the osteogenic and anti-osteoporosis effect of tea extract without any hepatotoxicity in ovariectomized rats." Frontiers in Endocrinology: 1690.

Katekar, Roshan, Sumati Sen, Mohammed Riyazuddin, Athar Husain, Richa Garg, Saurabh Verma, Kalyan Mitra, and Jiaur R. Gayen. "Augmented experimental design for bioavailability enhancement: A robust formulation of abiraterone acetate." Journal of Liposome Research 33, no. 1 (2023): 65- 76.

Husain, Athar, Mohammed Riyazuddin, Roshan Katekar, Saurabh Verma, Anees Ahmed Syed, Pragati Singh, Rakesh Maurya, Naibedya Chattopadhyay, and Jiaur R. Gayen. "Herb–drug interaction studies of ethanolic extract of Cassia occidentalis L. coadministered with acetaminophen, theophylline, omeprazole, methotrexate and methylprednisolone." Phytomedicine Plus 1, no. 1 (2021): 100008.

Riyazuddin, Mohammed, Athar Husain, Saurabh Verma, Roshan Katekar, Richa Garg, Sudhir Kumar, Sabbu Satish et al. "Correction: Simultaneous quantification of five biomarkers in ethanolic extract of Cassia occidentalis Linn. stem using liquid chromatography tandem mass spectrometry: application to its pharmacokinetic studies." RSC advance s 11, no. 54 (2021): 34424 - 34424 .

Verma, Saurabh, Umesh K. Goand, Athar Husain, Roshan A. Katekar, Richa Garg, and Jiaur R. Gayen. "Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability." Drug development researc h 82, no. 7 (2021): 927 -944 .

Riyazuddin, Mohammed, Athar Husain, Saurabh Verma, Roshan Katekar, Richa Garg, Sudhir Kumar, Sabbu Satish et al. "Simultaneous quantification of five biomarkers in ethanolic extract of Cassia occidentalis Linn. stem using liquid chromatography tandem mass spectrometry: application to its pharmacokinetic studies." RSC advance s 10, no. 8 (2020): 4579 -4588 .

Riyazuddin, Mohammed, Athar Husain, Guru R. Valicherla, Saurabh Verma, Anand P. Gupta, Kusuma S. Praveena, Akhilesh Singh et al. "Development and validation of LC -MS/MS method for quantification of novel PP2A – β -catenin signalling inhibitor, S011 -2111 in mice plasma: Application to its preclinical pharmacokinetic studies." Journal of Chromatography B 1130 (2019): 121829 .

 

Dr. Rimpy Pahwa

Assistant Professor - I

Dr. Rimpy completed her Ph.D. from Guru Jambheshwar University of Science & Technology, Hisar, and joined Amity University in August 2023. She was awarded a Gold Medal in her Master of Pharmacy and the prestigious DST-INSPIRE fellowship from the Government of India during her Ph.D. studies.

Dr. Rimpy brings valuable experience from both the pharmaceutical industry and academia, with a specialization in industrial pharmacy. Her research focuses on natural polymeric design, nanoformulations, scaffolds, and various drug delivery systems.

Her significant contributions to the field include research articles and book chapters published in various international journals, with the highest impact factor reaching 11.2. Her work has garnered 136 citations, and she holds an h-index of 7 in the areas of biomaterials and pharmaceutics.

 

RESEARCH INTERESTS

  • Polymers and its modification
  • Nanotechnology
  • Pharmaceutics
  • Drug delivery

 

SELECTED PUBLICATIONS

  1. Pooja Rani, Rimpy Pahwa, Vikas Verma, Meenakshi Bhatia. Preparation, characterization, and evaluation of ketoconazole-loaded pineapple cellulose green nanofiber gel. International Journal of Biological Macromolecules, 2024, 262, 130221. https://doi.org/10.1016/j.ijbiomac.2024.130221 (Current IF - 8.2)
  2. Rimpy Pahwa, Munish Ahuja. Nanocellulose-gellan cross-linked scaffolds for vaginal delivery of fluconazole. International Journal of Biological Macromolecules, 2023, 229, 668- 683. https://doi.org/10.1016/j.ijbiomac.2022.12.273 (Current IF - 8.2)
  3. Shakuntla Verma, Rimpy, Munish Ahuja. Carboxymethyl modification of cassia obtusifolia galactomannan and its evaluation as sustained release carrier. International Journal of Biological Macromolecules, 2020, 164, 3823-3834. https://doi.org/10.1016/j.ijbiomac.2020.08.231 (Current IF - 8.2)
  4. Abhishek, Rimpy, Munish Ahuja. Moringa gum-g-poly(N-vinyl-2-pyrrolidone) – a potential buccoadhesive polymer. International Journal of Biological Macromolecules, 2018, 109, 732- 739. https://doi.org/10.1016/j.ijbiomac.2017.12.112 (Current IF - 8.2)
  5. Rimpy, Abhishek, Munish Ahuja. Evaluation of carboxymethyl moringa gum as nanometric carrier. Carbohydrate Polymers, 2017, 174, 896-903. http://dx.doi.org/10.1016/j.carbpol.2017.07.022 (Current IF - 11.2)

 

Dr. Richa Dhingra

Assistant Professor - I

Dr. Richa works as an Assistant Professor in the Centre for Pharmaceutical Chemistry, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh. Previously she worked as Assistant professor in GD Goenka University, Gurugram. She has completed her Ph.D. from UIPS, Panjab University, Chandigarh. M.Pharmacy & B. Pharmacy from ISF College of Pharmacy, Moga. Her area of research expertise is design, synthesis and evaluation of drugs for treatment of BPH. She received DST-YSA-(SRF (Senior Research Fellow) and ICMR-SRF fellowships while pursuing her Ph.D. With over 11 years of teaching and research experience, Dr. Richa has made significant scholarly contributions. She has authored more than 30 research articles published by renowned international publishers like Elsevier, Bentham and many more. 

RESEARCH INTERESTS

«  Drug Designing (QSAR, Docking)

«  Synthesis and evaluation of steroidal 5 alpha reductase inhibitors

«  Pre ADME

Anti-cancer

SELECTED PUBLICATIONS

  • Renu Sharma, Pranjal Bansal, Lokesh Saini, Nidhi Sharma, Richa Dhingra*.Zuranolone, a neuroactive drug, used in the treatment of postpartum depression by modulation of GABAA receptors. Pharmacology Biochemistry and Behavior. 2024 (Impact Factor-3.3)
  • Yashika Bansal , Raghunath Singh, Rupinder Kaur Sodhi, Richa Dhingra, Mahendra Bishnoi, Kanthi Kiran Kondepudi, Anurag Kuhad. Kynurenine monooxygenase inhibition and associated reduced quinolinic acid reverses depression-like behaviour by upregulating Nrf2/ARE pathway in mouse model of depression: In-vivo and In-silico studies. Neuropharmacology, 2022; 215: 109169. (Impact Factor 5.27)
  • Richa Dhingra. “Exploration of Novel 5α-Reductase Inhibitors for Benign prostatic Hyperplasia by 2D/3D QSAR, Cytotoxicity, Pre-ADME and Docking Studies”. Current topics in Medicinal Chemistry. 2018, 18, 2816-2834. (Impact factor: 2.9).
  • Suryanarayan Biswal1, Debashree Das, Richa Dhingra, Kalpana Barhwal, Ashish Kumar, Neelima Dhingra, Sunil Kumar Hota1, Om Prakash Chaurasia, Salidroside reduced lipofuscin deposition by preventing mitophagy in global hypoxic condition. Neurobiology of Disease. 2018, 116, 39-52. (Impact factor 7.04)
  • Manav Malhotra, Ravindra K. Rawal, Dipan Malhotra, Richa Dhingra. Synthesis, characterization and pharmacological evaluation of (Z)-2-(5-(biphenyl-4-yl)-3-(1- (imino) ethyl)-2, 3-dihydro-1,3,4-oxadiazol-2-yl) phenol derivatives as potent antimicrobial and antioxidant agents. Arabian Journal of chemistry. 2013, 10, S1022- S1031 (Impact Factor 5.3).

 

Dr. Prakash Haloi

Dr. Prakash Haloi completed his PhD from the National Institute of Science Education & Research (NISER), Bhubaneswar, affiliated with Homi Bhabha National Institute (HBNI) University. Before joining Amity University, Noida, he worked as a Post-Doctoral Fellow at the Drug Discovery Lab, School of Biological Sciences, National Institute of Science Education & Research (NISER), Bhubaneswar. In July 2024, he joined as a Faculty member - Pharmacology at the Amity Institute of Pharmacy (AIP), Amity University Sector – 125, Noida - 201303, India.

 

He completed his M. Pharm Pharmacology (2011-2013) from Sikkim University under the AICTE Scholarship after Clearing the Graduate Pharmacy Aptitude Test (GPAT) 2011 (AICTE, New Delhi). Following the completion of his M. Pharm, he joined as a Research Fellow (Jan 2014-Dec 2016) in the Department of Pharmacology and Toxicology, College of Veterinary Sciences, Assam Agricultural University, Khanapara, Guwahati -781022 (Assam). In January 2017, he joined the NISER PhD Program through a DAE Scholarship to pursue my doctoral studies in Pharmaceutical Biology. His Ph.D. thesis centers on the characterization and development of functionalized polymers by utilizing material science and nanotechnology, such as hydrogel, micelle, nanogel, and nanoparticles, for implementation in the biomedical fields.

 

Dr. Haloi has 9.5 years of research experience in the research areas of localized drug delivery, pharmacology and toxicology, materials science, cancer biology, wound healing, inflammatory diseases, and nanotechnology. Apart from his Ph.D. thesis work, he worked on different collaborative works in the fields of nano-based therapy for wound healing, cancer nanotechnology, biomaterials for medical implants, and photothermal therapy for cancer treatment.

 

He also possesses extensive hands-on expertise in animal handling, small animal surgical procedures, and mammalian cell culture. Dr. Haloi has published more than 20 peer-reviewed research papers/review/book chapters with more than 325 citations, h-index 10, and i10-index 10.

 

RESEARCH INTERESTS

«  Pre-clinical Pharmacology & Toxicology

«  Localized Drug Delivery & Nanomedicine

«  Cancer Nanotherapeutics and Theranostics

«  Nanotherapeutics for  Autoimmune  Conditions

«  Biomaterials & Tissue Engineering

«  Biomaterials for Wound Care and Management

SELECTED PUBLICATIONS

  1. Roy, S.,# Haloi, P.,# Choudhary, R., Chawla, S., Kumari, M., Konkimalla, V.B., Jaiswal, A., 2023. Quaternary Pullulan functionalized 2D MoS2 glycosheets: A potent bactericidal nanoplatforms promoting safe and efficient wound disinfection and healing. ACS Appl. Mater. Interfaces. https://doi.org/10.1021/acsami.3c04390 # Equal Contribution (IF-9.5)
  2. Singh, P.,# Haloi, P.,# Singh, K., Roy, S., Sarkar, A., et al. 2023. Palladium Nanocapsules for Photothermal Therapy in the NIR II Biological Window. ACS Appl. Mater. Interfaces. https://doi.org/10.1021/acsami.3c06186. #Equal Contribution (IF-9.5)
  3. Haloi, P., Chawla, S., Konkimalla, V.B., 2023. Thermosensitive smart hydrogel of PEITC ameliorates the therapeutic efficacy in rheumatoid arthritis. Eur. J. Pharm. Sci., 181:106367. doi: 10.1016/j.ejps.2022.106367. (IF-5.2)
  4. Haloi, P., Lokesh, B.S., Chawla, S., Konkimalla, V.B., 2023. Formulation of a dual drug-loaded nanoparticulate co-delivery hydrogel system and its validation in rheumatoid arthritis animal model. Drug Deliv., 30(1):2184307. doi: 10.1080/10717544.2023.2184307. (IF-6.9)
  5. Roy, S.,# Haloi, P.,# Lokesh, B.S., Chawla, S., Konkimalla, V.B., Jaiswal, A. 2023. Biocompatible Quaternary Pullulan functionalized 2D MoS2 Glycosheet-based Non-leaching & Infection-resistant Coatings for Indwelling Medical Implants. Journal of Materials Chemistry B. DOI: 10.1039/d3tb01816d #Equal Contribution (IF-7.0)

 

Dr. Saman Fatima

Dr. Saman Fatima is an ardent researcher who is committed to expanding the frontiers of nanomedicine and pharmaceutical research. Her journey began with a bachelor’s degree in pharmacy from Jamia Hamdard, New Delhi, where she graduated with First Division and Distinction. Building on that foundation, she conducted her M. Pharm dissertation at the National Institute of Immunology (NII), New Delhi on fabricating PLGA-based nanoparticles for oral permeability enhancement of BCS Class-III drug, amikacin and secured first rank in her cohort. Along with having her study published in a reputable international journal, she was honoured early in her career with the Resomer® Award 2018, which is worth 1500 € and acknowledges her research as the best work submitted from Asia. She later received a Ph.D. in Pharmaceutics from Jamia Hamdard with her research centred on designing and developing novel nanoformulation of anti-apoptotic agent to treat cerebral ischemia. The publication of her work in the journal "Biomaterials" with an impact factor of 12.8 and the subsequent acquisition of a patent attest to her academic excellence and scientific rigor. Dr. Saman obtained funding for her Ph.D. via national fellowships, such as the Jamia Hamdard-Silver Jubilee Fellowship and the ICMR-SRF. In addition to her academic pursuits, she has gained industry experience as a Specialist in Medical and Pharmaceutical Writing, collaborating with clients to create regulatory documents, manuscripts, and scientific support materials. Dr. Saman has also qualified Graduate Pharmacy Aptitude Test (GPAT) conducted by AICTE in the year 2018 with 97.06 percentile. Her oral and poster presentations at numerous national and international conferences have earned her multiple accolades including the Young Scientist Award (Women Ph.D. Scholar and Assistant Professor Category), First Position in the Ph.D. North Zone Category, and Third Position in the Overall Category, etc. She is the first author of one review article and five research papers published in esteemed international journals with high impact factors. Additionally, Dr. Saman has authored several book chapters for Academic Press, Springer, and Elsevier. Dr. Saman currently serves as an Assistant Professor at the Amity Institute of Pharmacy, Amity University, Noida.

RESEARCH INTERESTS

• Design, Development and Optimization of Nanoformulation via Quality by Design Principles • Physicochemical Characterization of Nanoformulation • Pharmacokinetic Studies • Pharmacodynamic Studies • Oral Permeability Enhancement via Polymeric Nanoparticles • Protein Nanoparticles to Attenuate Ischemic Stroke and Reperfusion Injury • Brain Targeted Delivery

SELECTED PUBLICATIONS

1. Fatima, S., Ali, M., Quadri, S.N., Beg, S., Samim, M., Parvez, S., Abdin, M.Z., Mishra, P. and Ahmad, F.J. (2022). Crafting ?-L-Glutamyl-l-Cysteine layered Human Serum Albumin-nanoconstructs for brain targeted delivery of ropinirole to attenuate cerebral ischemia/reperfusion injury via “3A approach”. Biomaterials, 289, 121805. (I.F. – 12.8) 2. Fatima, S., Iqbal, Z., Panda, A.K., Samim, M., Talegaonkar, S. and Ahmad, F.J.(2018). Polymeric nanoparticles as a platform for permeability enhancement of class III drug amikacin. Colloids and Surfaces B: Biointerfaces, 169, 206-213. (I.F. – 5.4) 3. Fatima, S., Mohammad, T., Jairajpuri, D.S., Rehman, M.T., Hussain, A., Samim, M., Ahmad, F.J., Alajmi, M.F. and Hassan, M.I. (2020). Identification and evaluation of glutathione conjugate gamma-l-glutamyl-l-cysteine for improved drug delivery to the brain. Journal of Biomolecular Structure and Dynamics, 38(12), 3610-3620. (I.F. –4.4) 4. Fatima, S., Quadri, S.N., Parveen, S., Beg, S., Barkat, M.A., Samim, M., Abdin, M.Z. and Ahmad, F.J. (2021). Nanomedicinal strategies as emerging therapeutic avenues to treat and manage cerebral ischemia. CNS & Neurological Disorders-Drug Targets, 20(2), 125-144. (I.F. – 2.7) 5. Fatima, S., Beg, S., Samim, M. and Ahmad, F.J. (2019). Application of chemometric approach for development and validation of high performance liquid chromatography method for estimation of ropinirole hydrochloride. Journal of separation science, 42(21), 3293-3301. (I.F. – 2.8) 1. Fatima, S., Panda, A.K., Talegaonkar, S., Iqbal, Z. and Ahmad, F.J. (2019). Optimization and designing of amikacinloaded poly d, l-lactide-co-glycolide nanoparticles for effective and sustained drug delivery. Journal of Pharmacy & Bioallied Sciences, 11(1), 83. (I.F. – 0.8)